{"taxa": [{"scientific_name": "iris postii mouterde", "compounds": ["isovitexin", "\u03b5-viniferin", "isotectorigenin", "swertisin", "2\u201d-o-\u03b1-l-rhamnopyranosyl swertisin", "trans-resveratrol 3,4\u2032-o-di-\u03b2-d-glucopyranoside", "l-tryptophan", "androsin"], "accepted_name": "Iris postii", "accepted_species": "Iris postii", "accepted_genus": "Iris", "inchi_keys": {"isovitexin": "MYXNWGACZJSMBT-VJXVFPJBSA-N", "isotectorigenin": "UYLQOGTYNFVQQX-UHFFFAOYSA-N", "swertisin": "ABRULANJVVJLFI-DGHBBABESA-N", "l-tryptophan": "QIVBCDIJIAJPQS-VIFPVBQESA-N", "androsin": "QUOZWMJFTQUXON-UXXRCYHCSA-N"}, "inchi_key_simps": {"isovitexin": "MYXNWGACZJSMBT", "isotectorigenin": "UYLQOGTYNFVQQX", "swertisin": "ABRULANJVVJLFI", "l-tryptophan": "QIVBCDIJIAJPQS", "androsin": "QUOZWMJFTQUXON"}}, {"scientific_name": "iris germanica l", "compounds": ["5,2\u2032-dihydroxy-3-methoxy-6,7-methylenedioxyflavone", "3\u2032-o-metyliriskumaonin", "irilone", "cirsiliol-4\u2032-o-glucopyranoside", "irisgermanical a", "germanaism c", "p-hydroxy benzoic acid", "irisamides a", "7-o-methyl-tectorigenin-4\u2032-o-[\u03b2-d-glucopyranosyl-(1\u21926)-\u03b2-d-glucopyranoside]", "irilin d", "irigenin s", "delphanin", "methyl (1r,3r)-1-methyl-2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indole-3-carboxylate", "2,4\u2032,6-trihydroxy-4-methoxybenzophenone-2-o-\u03b2-d-glucoside", "chlorogenic acid", "irigermanone", "pid", "caffeic acid", "mangiferin", "germanaism b", "iridal", "2-(furan-2-yl)-5-(2,3,4-trihydroxybutyl)-1,4-diazine", "8-hydroxyirilone", "6-hydroxymethyl-3-pyridinol", "dihydroquercetin-7,3\u2032-dimethylether-5-o-\u03b2-d-glucopyranoside", "(+)-(2r,3s)-catechin", "(1s,3r)-methyl 1-methyl-2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indole-3-carboxylate", "5,7,3\u2032-trihydroxy-6,4\u2032-dimethoxyisoflavone-7-o-[\u03b2-d-glucopyranosyl-(1\u21926)-\u03b2-d-glucopyranoside]", "iristectorigenin a", "4-(9h-\u03b2-carbolin-1-yl)-4-oxobut-2-enoic acid methyl ester", "dihydroquercetin-7,3\u2032-dimethylether", "5,7-dihydroxy-3-(3\u2032-hydroxy-4\u2032,5\u2032-dimethoxy)-8-methoxy-4h-1-benzopyran-4-one", "iristectorone k", "iridobelamal a", "germanaism d", "dihydroquercetin-7,4\u2032-dimethylether", "\u03b1-dehydroirigermanal", "homotectoridin", "iridin a", "\u03b3-irigermanal", "tectorigenin", "5,7,8-trihydroxy-3-(4-methoxyphenyl)-2-methyl-4h-chromen-4-one", "irisolidone", "8-hydroxyirilone 5-methyl ether", "iriflogenin", "muningin", "irisolone", "nigricanin", "irisgermanical c", "irilone 4\u2032-methyl ether", "iriside a", "isopeonol", "ferulic acid", "1-(2-(6\u2032-hydroxy-2\u2032-methylcyclohex-1\u2032-enyloxy)-5-methoxyphenyl)ethanone", "3-\u03b2-d-ribofuranosyluracil", "\u03b3-irone", "\u03b1-irigermanal", "irigenin", "germanaism f", "irilone 4\u2032-o-[\u03b2-d-glucopyranosyl (1\u21926)\u03b2-d-glucopyranoside]", "isoiridogermanal", "protocatechuic acid", "irisolidone-7-o-\u03b2-d-glucopyranoside", "iridin s", "irisxanthone", "irilin a", "germanaism e", "iriflogenin 4\u2032-o-[\u03b2-d-glucopyranosyl-(1\u21926)-\u03b2-d-glucopyranoside]", "2-acetoxy-3,6-dimethoxy-1,4-benzoquinone", "irilone 4\u2032-o-\u03b2-d-glucopyranoside", "\u03b1-irone", "6,6-ditetradecyl-6,7-dihydrooxepin-2(3h)-one", "6,7-dihydroxy-3-(4-methoxyphenyl)-2-methyl-4h-chromen-4-one", "2-amino-1h-imidazo-[4,5-b]pyrazine", "irisflorentin", "dichotomitin", "irifloside", "irilin b", "5,7,2\u2032-trihydroxy-6-methoxyflavanone", "iripallidal", "\u03b2-irone", "naringenin", "tectoridin", "16-o-acetylisoiridogermanal", "29-acetoxyspiroiridal", "germanaism g", "iridin", "3-hydroxy-5-methoxyacetophenone", "ombuin", "5,3\u2032-dihydroxy-4\u2032,5\u2032-dimethoxyisoflavone 7-o-glucoside", "iristectorigenin b", "iristectorin a", "iriflorental", "androsin", "germanaism a", "genistein", "germanaism h", "5,7-dihydroxy-3-(3\u2032-methoxy-4\u2032-hydroxyphenyl)-6-methoxy-4h-1-benzopyran-4-one", "irisamides b", "iriskashmirianin a", "acetovanillone", "1,2,3,4-tetrahydro-\u03b2-carboline-3-carboxylic acid", "iridogermanal", "irisgermanical b"], "accepted_name": "Iris \u00d7 germanica", "accepted_species": "Iris \u00d7 germanica", "accepted_genus": "Iris", "inchi_keys": {"5,2\u2032-dihydroxy-3-methoxy-6,7-methylenedioxyflavone": "MKHNQPPKUWUEFB-UHFFFAOYSA-N", "irilone": "NUGRQNBDTZWXTP-UHFFFAOYSA-N", "germanaism c": "MMBFBXQUZNSAAJ-MVKAXRKBSA-N", "p-hydroxy benzoic acid": "FJKROLUGYXJWQN-UHFFFAOYSA-N", "irilin d": "VYCWOMOGAIPFPW-UHFFFAOYSA-N", "delphanin": "OUUYNFWYLXMNQZ-HNPHZNNWSA-N", "methyl (1r,3r)-1-methyl-2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indole-3-carboxylate": "WZHYQHKXXRMALW-PRHODGIISA-N", "chlorogenic acid": "CWVRJTMFETXNAD-JUHZACGLSA-N", "pid": "NFBAXHOPROOJAW-UHFFFAOYSA-N", "caffeic acid": "QAIPRVGONGVQAS-DUXPYHPUSA-N", "mangiferin": "AEDDIBAIWPIIBD-ZJKJAXBQSA-N", "iridal": "KWHXMASXPBOSRE-JKIIOOKNSA-N", "2-(furan-2-yl)-5-(2,3,4-trihydroxybutyl)-1,4-diazine": "KLACITZZUQUMIS-UHFFFAOYSA-N", "6-hydroxymethyl-3-pyridinol": "NESFDGDRYVANBC-UHFFFAOYSA-N", "(1s,3r)-methyl 1-methyl-2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indole-3-carboxylate": "WZHYQHKXXRMALW-QPUJVOFHSA-N", "iristectorigenin a": "WRZOUWHPDDOJNR-UHFFFAOYSA-N", "4-(9h-\u03b2-carbolin-1-yl)-4-oxobut-2-enoic acid methyl ester": "IAXJBVZHNNLOND-VOTSOKGWSA-N", "iridobelamal a": "KVTCHSWVSFQOTP-BTUOOTBZSA-N", "homotectoridin": "LACQUZXTVNKQKI-QSXUWXSHSA-N", "\u03b3-irigermanal": "RQLMZJMQAUSPIT-IFFFSDDRSA-N", "tectorigenin": "OBBCRPUNCUPUOS-UHFFFAOYSA-N", "5,7,8-trihydroxy-3-(4-methoxyphenyl)-2-methyl-4h-chromen-4-one": "RVSOAWYDDFXPDH-UHFFFAOYSA-N", "irisolidone": "VOOFPOMXNLNEOF-UHFFFAOYSA-N", "iriflogenin": "XSPWJJMLMZGHNF-UHFFFAOYSA-N", "muningin": "KVSCSPAYYVSPTI-UHFFFAOYSA-N", "irisolone": "RSSZOUXCQUJNKL-UHFFFAOYSA-N", "nigricanin": "XTCYRFROIBWDPU-UHFFFAOYSA-N", "isopeonol": "XPHIPEXPAGCEBM-UHFFFAOYSA-N", "3-\u03b2-d-ribofuranosyluracil": "NBNBAENCKIJZAH-XVFCMESISA-N", "\u03b3-irone": "MVPDTCQYNRKWJA-UZPJXDOOSA-N", "\u03b1-irigermanal": "GJYZRMAFYKGFKM-FLUGPJFHSA-N", "irigenin": "TUGWPJJTQNLKCL-UHFFFAOYSA-N", "isoiridogermanal": "KVTCHSWVSFQOTP-YFPNSAJKSA-N", "protocatechuic acid": "YQUVCSBJEUQKSH-UHFFFAOYSA-N", "irisxanthone": "MTQVPZUZBBTLNO-HSLVGEKZSA-N", "irilin a": "HVYFRUIBILXVBU-UHFFFAOYSA-N", "2-acetoxy-3,6-dimethoxy-1,4-benzoquinone": "BBQAWGBALTVHFN-UHFFFAOYSA-N", "\u03b1-irone": "JZQOJFLIJNRDHK-CMDGGOBGSA-N", "6,6-ditetradecyl-6,7-dihydrooxepin-2(3h)-one": "DPCINRXRMFZCEJ-UHFFFAOYSA-N", "6,7-dihydroxy-3-(4-methoxyphenyl)-2-methyl-4h-chromen-4-one": "GNTJDACLLNJRSC-UHFFFAOYSA-N", "2-amino-1h-imidazo-[4,5-b]pyrazine": "ICNRJMRTXYQGEC-UHFFFAOYSA-N", "irisflorentin": "RISXUTCDCPHJFQ-UHFFFAOYSA-N", "dichotomitin": "PFFOGGCBLWTCPM-UHFFFAOYSA-N", "irifloside": "ZYXMBDJAUWLBQW-PSIBPZGZSA-N", "irilin b": "SRXIDIOVDWRHPY-UHFFFAOYSA-N", "5,7,2\u2032-trihydroxy-6-methoxyflavanone": "VIYRCVBDGLGTOV-UHFFFAOYSA-N", "\u03b2-irone": "BGKCUGPVLVNPSG-CMDGGOBGSA-N", "naringenin": "FTVWIRXFELQLPI-ZDUSSCGKSA-N", "tectoridin": "CNOURESJATUGPN-UDEBZQQRSA-N", "16-o-acetylisoiridogermanal": "YLBQHEKHEQVFLJ-RSBZPSGXSA-N", "iridin": "LNQCUTNLHUQZLR-OZJWLQQPSA-N", "ombuin": "BWORNNDZQGOKBY-UHFFFAOYSA-N", "iristectorigenin b": "WRZOUWHPDDOJNR-UHFFFAOYSA-N", "iristectorin a": "HFODKTZIQVSGJO-ZTATXHNCSA-N", "androsin": "QUOZWMJFTQUXON-UXXRCYHCSA-N", "genistein": "TZBJGXHYKVUXJN-UHFFFAOYSA-N", "5,7-dihydroxy-3-(3\u2032-methoxy-4\u2032-hydroxyphenyl)-6-methoxy-4h-1-benzopyran-4-one": "CCRPIWFQMLICCY-UHFFFAOYSA-N", "acetovanillone": "DFYRUELUNQRZTB-UHFFFAOYSA-N", "1,2,3,4-tetrahydro-\u03b2-carboline-3-carboxylic acid": "FSNCEEGOMTYXKY-UHFFFAOYSA-N", "iridogermanal": "CMKAMRUVQONAPO-FALQBROGSA-N"}, "inchi_key_simps": {"5,2\u2032-dihydroxy-3-methoxy-6,7-methylenedioxyflavone": "MKHNQPPKUWUEFB", "irilone": "NUGRQNBDTZWXTP", "germanaism c": "MMBFBXQUZNSAAJ", "p-hydroxy benzoic acid": "FJKROLUGYXJWQN", "irilin d": "VYCWOMOGAIPFPW", "delphanin": "OUUYNFWYLXMNQZ", "methyl (1r,3r)-1-methyl-2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indole-3-carboxylate": "WZHYQHKXXRMALW", "chlorogenic acid": "CWVRJTMFETXNAD", "pid": "NFBAXHOPROOJAW", "caffeic acid": "QAIPRVGONGVQAS", "mangiferin": "AEDDIBAIWPIIBD", "iridal": "KWHXMASXPBOSRE", "2-(furan-2-yl)-5-(2,3,4-trihydroxybutyl)-1,4-diazine": "KLACITZZUQUMIS", "6-hydroxymethyl-3-pyridinol": "NESFDGDRYVANBC", "(1s,3r)-methyl 1-methyl-2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indole-3-carboxylate": "WZHYQHKXXRMALW", "iristectorigenin a": "WRZOUWHPDDOJNR", "4-(9h-\u03b2-carbolin-1-yl)-4-oxobut-2-enoic acid methyl ester": "IAXJBVZHNNLOND", "iridobelamal a": "KVTCHSWVSFQOTP", "homotectoridin": "LACQUZXTVNKQKI", "\u03b3-irigermanal": "RQLMZJMQAUSPIT", "tectorigenin": "OBBCRPUNCUPUOS", "5,7,8-trihydroxy-3-(4-methoxyphenyl)-2-methyl-4h-chromen-4-one": "RVSOAWYDDFXPDH", "irisolidone": "VOOFPOMXNLNEOF", "iriflogenin": "XSPWJJMLMZGHNF", "muningin": "KVSCSPAYYVSPTI", "irisolone": "RSSZOUXCQUJNKL", "nigricanin": "XTCYRFROIBWDPU", "isopeonol": "XPHIPEXPAGCEBM", "3-\u03b2-d-ribofuranosyluracil": "NBNBAENCKIJZAH", "\u03b3-irone": "MVPDTCQYNRKWJA", "\u03b1-irigermanal": "GJYZRMAFYKGFKM", "irigenin": "TUGWPJJTQNLKCL", "isoiridogermanal": "KVTCHSWVSFQOTP", "protocatechuic acid": "YQUVCSBJEUQKSH", "irisxanthone": "MTQVPZUZBBTLNO", "irilin a": "HVYFRUIBILXVBU", "2-acetoxy-3,6-dimethoxy-1,4-benzoquinone": "BBQAWGBALTVHFN", "\u03b1-irone": "JZQOJFLIJNRDHK", "6,6-ditetradecyl-6,7-dihydrooxepin-2(3h)-one": "DPCINRXRMFZCEJ", "6,7-dihydroxy-3-(4-methoxyphenyl)-2-methyl-4h-chromen-4-one": "GNTJDACLLNJRSC", "2-amino-1h-imidazo-[4,5-b]pyrazine": "ICNRJMRTXYQGEC", "irisflorentin": "RISXUTCDCPHJFQ", "dichotomitin": "PFFOGGCBLWTCPM", "irifloside": "ZYXMBDJAUWLBQW", "irilin b": "SRXIDIOVDWRHPY", "5,7,2\u2032-trihydroxy-6-methoxyflavanone": "VIYRCVBDGLGTOV", "\u03b2-irone": "BGKCUGPVLVNPSG", "naringenin": "FTVWIRXFELQLPI", "tectoridin": "CNOURESJATUGPN", "16-o-acetylisoiridogermanal": "YLBQHEKHEQVFLJ", "iridin": "LNQCUTNLHUQZLR", "ombuin": "BWORNNDZQGOKBY", "iristectorigenin b": "WRZOUWHPDDOJNR", "iristectorin a": "HFODKTZIQVSGJO", "androsin": "QUOZWMJFTQUXON", "genistein": "TZBJGXHYKVUXJN", "5,7-dihydroxy-3-(3\u2032-methoxy-4\u2032-hydroxyphenyl)-6-methoxy-4h-1-benzopyran-4-one": "CCRPIWFQMLICCY", "acetovanillone": "DFYRUELUNQRZTB", "1,2,3,4-tetrahydro-\u03b2-carboline-3-carboxylic acid": "FSNCEEGOMTYXKY", "iridogermanal": "CMKAMRUVQONAPO"}}, {"scientific_name": "iris persica l", "compounds": ["isovitexin", "(-)-trans-resveratrol-3-o-\u03b2-d-glucopyranoside", "embinin", "tectorigenin"], "accepted_name": "Iris persica", "accepted_species": "Iris persica", "accepted_genus": "Iris", "inchi_keys": {"isovitexin": "MYXNWGACZJSMBT-VJXVFPJBSA-N", "embinin": "OXTGLFRGBDFBHI-FFIOIDJNSA-N", "tectorigenin": "OBBCRPUNCUPUOS-UHFFFAOYSA-N"}, "inchi_key_simps": {"isovitexin": "MYXNWGACZJSMBT", "embinin": "OXTGLFRGBDFBHI", "tectorigenin": "OBBCRPUNCUPUOS"}}], "text": "moleculesArticlePhytochemistry and Biological Activities of Iris SpeciesGrowing in Iraqi Kurdistan and Phenolic Constituents of theTraditional Plant Iris postiiHawraz Ibrahim M. Amin 1,2,* , Faiq H. S. Hussain 3, Soran K. Najmaldin 4, Zaw Min Thu 5 ,Mohammed Farhad Ibrahim 6, Gianluca Gilardoni 7 and Giovanni Vidari 3,8,*\u0001\u0002\u0003\u0001\u0004\u0005\u0006\u0007\b\u0001\u0001\u0002\u0003\u0004\u0005\u0006\u0007Citation: Amin, H.I.M.; Hussain,F.H.S.; Najmaldin, S.K.; Thu, Z.M.;Ibrahim, M.F.; Gilardoni, G.; Vidari, G.Phytochemistry and BiologicalActivities of Iris Species Growing inIraqi Kurdistan and PhenolicConstituents of the Traditional PlantIris postii. Molecules 2021, 26, 264.https://doi.org/10.3390/molecules26020264Academic Editor: Natalizia MiceliReceived: 11 December 2020Accepted: 1 January 2021Published: 7 January 2021Publisher\u2019s Note: MDPI stays neu-tral with regard to jurisdictional clai-ms in published maps and institutio-nal affiliations.Copyright: \u00a9 2021 by the authors. Li-censee MDPI, Basel, Switzerland.This article is an open access articledistributed under the terms and con-ditions of the Creative Commons At-tribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).1 Dipartimento di Scienze del Farmaco, Universit\u00e0 del Piemonte Orientale, Largo Donegani 2,28100 Novara, Italy2 Department of Chemistry, College of Science, Salahaddin University-Erbil, Erbil 44001, Kurdistan Region, Iraq3 Medical Analysis Department, Faculty of Science, Tishk International University,Erbil 44001, Kurdistan Region, Iraq; faiq.hussain@tiu.edu.iq4 Biology Department, Faculty of Education, Tishk International University, Erbil 44001, Kurdistan Region, Iraq;soran.kayfi@tiu.edu.iq5 Department of Chemistry, Kalay University, Kalay 03044, Myanmar; zawminthu87@gmail.com6 Department of Drug Science, University of Pavia, Viale Taramelli 10, 27100 Pavia, Italy; gardy1988@gmail.com7 Departamento de Qu\u00edmica y Ciencias Exactas, Universidad T\u00e9cnica Particular de Loja, Calle MarcelinoChampagnat s/n, Loja 110107, Ecuador; ggilardoni@utpl.edu.ec8 Dipartimento di Chimica, Universit\u00e0 di Pavia, Via Taramelli 12, 27100 Pavia, Italy* Correspondence: hawraz.mohammedamin@uniupo.it (H.I.M.A.); vidari@unipv.it (G.V.);Tel.: +39-380-6359340 (H.I.M.A.); +39-334-3782582 (G.V.)Abstract: A dozen Iris species (Iridaceae) are considered traditional remedies in Kurdistan, especiallyfor treating inflammations. Phytochemical studies are still scarce. The information reported inthe literature about Iris species growing in Kurdistan has been summarized in the first part of thispaper, although, except for Iris persica, investigations have been performed on vegetal samplescollected in countries different from Kurdistan. In the second part of the work, we have investigated,for the first time, the contents of the methanolic extracts of Iris postii aerial parts and rhizomesthat were collected in Kurdistan. Both extracts exhibited a significant dose-dependent free radicalscavenging and total antioxidant activities, comparable to those of ascorbic acid. Medium-pressureliquid chromatographic separations of the two extracts afforded L-tryptophan, androsin, isovitexin,swertisin, and 2\u201d-O-\u03b1-L-rhamnopyranosyl swertisin from the aerial parts, whereas \u03b5-viniferin, trans-resveratrol 3,4\u2032-O-di-\u03b2-D-glucopyranoside, and isotectorigenin were isolated from the rhizomes.This is the first finding of the last three metabolites from an Iris species. The various remarkablebiological activities of isolated compounds scientifically sustain the traditional use of I. postii as amedicinal plant.Keywords: phenolics; terpenoids; isoflavones; swertisin 6-C-glycosides; resveratrol 3,4\u2032-O-diglucoside;Iris postii; antioxidant activity; Kurdish medicinal plants1. IntroductionTraditional medicines still hold an important role among health care practices ofmany countries, including Arab countries and Iraqi Kurdistan [1]. A Neanderthal burialdiscovered at Shanidar cave (number IV in the series of skeletons) in northern Iraq, datedapproximately 60,000 years ago [2], is evidence that herbal medicine has probably beenpracticed in the mountains and plains of Kurdistan since the dawn of civilization. Indeed,a well-organized form of medicine, which made intense uses of plant-derived drugs,remedies, potions and oils, can be traced back in Iraq to the Sumerian period (3000\u20131970B.C.) and then to the Babylonian and Assyrian periods (1970\u2013539 B.C). Later, this knowledgeMolecules 2021, 26, 264. https://doi.org/10.3390/molecules26020264 https://www.mdpi.com/journal/moleculesMolecules 2021, 26, 264 2 of 21was translated and enriched by Arab physicians during the Abbasid period (500\u20131038 A.D).Still today, the majority of the approximately 1500 plants used in Iraq are appreciated fortheir medicinal and aromatic properties. Most medicinal plants are collected from theirwild habitats, but some are also cultivated [3].Medicinal herbs growing in Iraqi Kurdistan are especially used by people living inthe villages on the mountains and in the rural areas; however, sellers of natural medicinalproducts (Figure 1) are also present in the bazaars of the main towns, such as Erbil andSulaymaniya [4,5].Molecules 2021, 26, x FOR PEER REVIEW 2 of 22 and then to the Babylonian and Assyrian periods (1970\u2013539 B.C). Later, this knowledge as translated and enriched by Arab physicians during the Abbasid period (500\u20131038 A.D). Still oday, the majority of the approximately 1500 plants used in Iraq are ppreci-at d for their medicinal and aromatic properties. Most medici al plants are collected from their wild habitats, but some are also cultivated [3]. e ici al er s r i i Ira i r ista are especiall use by people living in the villages on the ountains and in the rural areas; ho ever, sellers of natural edicinal products (Figure 1) are also present in the bazaars of the ain to ns, such as Erbil and Sulay aniya [4,5]. Figure 1. A Kurdish seller of traditional remedies (photo taken by H.I.M.A.). Despite the wide use of herbal remedies, phytochemical studies on Kurdistan medic-inal plants are still in their infancy and only a few papers have been published so far that describe the structures and bioactivities of isolated metabolites. As part of our ongoing project on scientific validation of Kurdistan traditional plants, we directed our attention toward the genus Iris. This large genus of the family Iridaceae (Angiosperms) contains about 260\u2212300 species [6,7] of perennial plants growing from creeping rhizomes (rhizom-atous irises) or, in drier climates, from bulbs (bulbous irises). The showy flowers are char-acterized by a violet-like scent. The plants grow in temperate regions across the Northern Hemisphere, from Eurasia to North America [8]. Many Iris species are ornamental plants; however, they are also used in various traditional medicines for the treatment of inflam-mations, cancer, bacterial and viral infections, and other diseases. Extensive phytochemi-cal investigations of the genus have led to the isolation of different isoprenoids, flavo-noids, isoflavonoids and their glycosides, xanthones, quinones, and stilbene glycosides, among others [8,9]. On the other hand, isolated bioactive compounds have shown anti-bacterial, anti-neoplastic, antioxidant, cytotoxic, anti-plasmodial, molluscicidal, anti-in-flammatory, phytoestrogenic and antituberculosis properties [9]. Moreover, an essence called \u201corris butter\u201d and an absolute essential oil with the scent of the flowers are derived from the bulbs of some Iris, e.g., I. florentina and I. germanica; they are used in the manu-facture of luxury expensive perfumes, such as Chanel No. 19 (1970) and So pretty by Cartier (1995) [10]. Twelve species of Iris are reported to grow in Iraq; in the Kurdistan region, they occur especially on mountainous regions, such as Halgurd Mountain (Choman) and Korek Mountain (Rawanduz). These plants include Iris aucheri (Baker) Sealy, I. barnumiae Baker et Foster, I. caucasica Hoffm., I. gatesii Foster, I. germanica L., I. heylandiana Boiss. et Reut. ex Boiss., I. hymenospatha B. Mathew et Wendelbo, I. masia Dykes, I. persica L., I. postii Mouterde, I. pseudocaucasica Grossh., and I. reticulata M. Bieb. [11]. Of these species only I. germanica L. and I. persica L. have been investigated phytochemically. I. persica has been investigated by a Kurdish research group [12,13]; instead, due to the wide geographical distribution and economic importance, I. germanica has been subjected to several investi-gations in countries different from Kurdistan. The results of these investigations have Fig re 1. r is seller of tra itional re edies (photo taken by H.I. .A.).es ite the i e se f er al re edies, phytoche ical studies on Kurdistan medicinal plants are still in their infancy and only a few papers have be n published so far thatescri t e struct res and bioactivities of isolated etabolites. s part of our ongoingproject on scientific validation of Kurdistan traditional plants, we direct d our attention t -ward the genus Iris. This large genus of the family Iridaceae (Angiosperms) contains about260\u2013300 species [6,7] of perennial plants growing from creeping rhizomes (rhizomatousirises) or, in drier climates, from bulbs (bulbous irises). The showy flowers are charac-terized by a violet-like scent. The plants grow in temperate regions across the Northerne isphere, fro Eurasia to orth A erica [8]. any Iris species are orna ental plants;however, they are also used in various traditional medicines for the treatment of inflamma-tions, cancer, bacterial and viral infections, and other diseases. Extensive phytochemicalinvestigations of the genus have led to the isolation of different isoprenoids, flavonoids,isoflavonoids and their glycosides, xanthones, quinones, and stilbene glycosides, amongothers [8,9]. On the other hand, isolated bioactive compounds have shown antibacterial,anti-neoplastic, antioxidant, cytotoxic, anti-plasmodial, molluscicidal, anti-inflammatory,phytoestrogenic and antituberculosis properties [9]. Moreover, an essence called \u201corrisbutter\u201d and an absolute essential oil with the scent of the flowers are derived from the bulbsof some Iris, e.g., I. florentina and I. germanica; they are used in the manufacture of luxuryexpensive perfumes, such as Chanel No. 19 (1970) and So pretty by Cartier (1995) [10].Twelve species of Iris are reported to grow in Iraq; in the Kurdistan region, theyoccur especially on mountainous regions, such as Halgurd Mountain (Choman) and KorekMountain (Rawanduz). These plants include Iris aucheri (Baker) Sealy, I. barnumiae Baker etFoster, I. caucasica Hoffm., I. gatesii Foster, I. germanica L., I. heylandiana Boiss. et Reut. exBoiss., I. hymenospatha B. Mathew et Wendelbo, I. masia Dykes, I. persica L., I. postii Mouterde,I. pseudocaucasica Grossh., and I. reticulata M. Bieb. [11]. Of these species only I. germanica L.and I. persica L. have been investigated phytochemically. I. persica has been investigated bya Kurdish research group [12,13]; instead, due to the wide geographical distribution andeconomic importance, I. germanica has been subjected to several investigations in countriesdifferent from Kurdistan. The results of these investigations have been summarized inthe first part of this paper. The phytochemical literature reported in Scifinder and GoogleScholar databases up to August 2020 has been reviewed. In the second part of this paper,Molecules 2021, 26, 264 3 of 21we describe the results of our phytochemical investigation of non-volatile secondarymetabolites isolated from the aerial parts and rhizomes of Iris postii Mouterdi.2. Results and Discussion2.1. Literature Data about Iris germanica and Iris persica2.1.1. Iris germanicaIris germanica L. is probably the most thoroughly investigated Iris species. Rhizomeshave been traditionally used for various oral and topical applications, e.g., sores, freck-les [14], and to relieve teething-associated pain [15]. Root decoctions of the plant have beencommonly applied as antispasmodic, emmenagogue, diuretic, anti-insomnia, and cathar-tic agents [16]. They decrease smooth muscle activity in vivo and show anti-serotonineffects [17]. Extracts of I. germanica showed cytotoxic [18,19], antioxidant [20\u201322], an-timutagenic [22], antifungal [23], antimicrobial [24\u201326], anti-inflammatory [24,27], anti-biofilm [28], antiulcer [29], hypolipidemic [30], molluscicidal [31], and amyloid \u03b2 (A\u03b2)induced memory impairment activities [32]. The application of rhizomes in both traditionaland modern medicine has been mainly based on the presence of isoflavones and essentialoils in the extracts.IsoflavonoidsIsoflavonoids are mainly accumulate in the rhizomes and form the largest group offlavonoids isolated from I. germanica. Their structures (1\u201348) are shown in Figure 2, whereasthe reported biological activities are shown in Table 1.Iris isoflavonoids include germanaism A (1) [15,33,34], B (2) [15,17,33,34], C (3) [17],D (4) [17], E (5) [15,17], F (6) [17], G (7) [17], and H (8) [34], tectoridin (9) [35,36], iridin(10) [15,24,33,35,37\u201340], iridin A (11) [40], and S (12) [38,40,41], iristectorin A (13) [39],irisolidone-7-O-\u03b2-D-glucopyranoside (14) [15,37,42], 5,3\u2032-dihydroxy-4\u2032,5\u2032-dimethoxyiso-flavone 7-O-glucoside (15) [37], homotectoridin (16) [36], irilone (17) [14,15,24,34,38,40,42\u201345], ir-ilone 4\u2032-methyl ether (18) [14,25,38,40], irilone 4\u2032-O-\u03b2-D-glucopyranoside (19) [15,24,33,34,38,40],irilone 4\u2032-O-[\u03b2-D-glucopyranosyl (1\u21926)\u03b2-D-glucopyranoside] (20) [15], 8-hydroxyirilone(21) [38], 8-hydroxyirilone 5-methyl ether (22) [38], iriflogenin (23) [15,34,42,44], iriflogenin4\u2032-O-[\u03b2-D-glucopyranosyl-(1\u21926)-\u03b2-D-glucopyranoside] (24) [15], irifloside (25) [15,34], iris-florentin (26) [15,44,45], dichotomitin (27) [15,37], irisolone (nigricin) (28) [14,15,23,34,44\u201346], ni-gricanin (iriskashmirianin) (29) [42,44], iriskashmirianin A (30) [34], 3\u2032-O-metyliriskumaonin(iriskumaonin methyl ether) (31) [15,34,44,45], genistein (32) [35], 5,7-dihydroxy-3-(3\u2032-hydroxy-4\u2032,5\u2032-dimethoxy)-8-methoxy-4H-1-benzopyran-4-one (33) [14], muningin (34) [35],tectorigenin (35) [14,35], 7-O-methyl-tectorigenin-4\u2032-O-[\u03b2-D-glucopyranosyl-(1\u21926)-\u03b2-D-glucopyranoside] (36) [15], irigenin (37) [14,15,24,25,35,37\u201340,42,44,45], irigenin S (38) [24,38,40],irilin A (39) [31], B (40) [31], and D (41) [35], irisolidone (42) [15,23,24,37,38,40,42\u201346],iristectorigenin A (43) [14,39,44,45], 5,7-dihydroxy-3-(3\u2032-methoxy-4\u2032-hydroxyphenyl)-6-methoxy-4H-1-benzopyran-4-one (44) [14,45], iristectorigenin B (45) [35], 5,7,3\u2032-trihydroxy-6,4\u2032-dimethoxyisoflavone-7-O-[\u03b2-D-glucopyranosyl-(1\u21926)-\u03b2-D-glucopyranoside] (46) [15],5,7,8-trihydroxy-3-(4-methoxyphenyl)-2-methyl-4H-chromen-4-one (47) [47] and 6,7,-dihydroxy-3-(4-methoxyphenyl)-2-methyl-4H-chromen-4-one (48) [47]. Iris isoflavanoid structures canbe collected in five different groups, depending on whether they contain: (A) a methylene-dioxy group at C-6 and C-7 and an oxygenated group at C-4\u2032; (B) an OH group at C-5and a D-glucopyranosyl unit at 7-O; (C) different oxygenated functions but neither amethylenedioxy group nor a 7-O-D-glucopyranosyloxy unit; (D) a 2\u2032-OH-group; (E) amethyl group attached to C-2. Group A includes 4\u2032-O- mono-, di-, and triglycosides andone 3\u2032-O-monoglucoside; group B contains only 7-O-monoglucosides; group C containsonly 7-O- or 4\u2032-O-diglycosides, while no sugar residue occurs in isoflavonoids of groups Dand E. D-Glucopyranose is the only sugar present in mono- and diglucosides, whereas theonly known triglycoside (6) contains an additional L-rhamnopyranosyl moiety. Digluco-sides are \u03b2-D-glucopyranosyl-(1\u21926)-\u03b2-D-glucopyranosyl derivatives, whereas triglycoside6 is characterized by a \u03b2-D-glucopyranosyl-(1\u21922)-rutinosyl unit.Molecules 2021, 26, 264 4 of 21Molecules 2021, 26, x FOR PEER REVIEW 4 of 22 while no sugar residue occurs in isoflavonoids of groups D and E. D-Glucopyranose is the only sugar present in mono- and diglucosides, whereas the only known triglycoside (6) contains an additional L-rhamnopyranosyl moiety. Diglucosides are \u03b2-D-glucopyranosyl-(1\u21926)-\u03b2-D-glucopyranosyl derivatives, whereas triglycoside 6 is characterized by a \u03b2-D-glucopyranosyl-(1\u21922)-rutinosyl unit. Figure 2. Characteristic isoflavonoids isolated from Iris germanica. Figure 2. Characteristic isoflavonoids isolated from Iris germanica.Molecules 2021, 26, 264 5 of 21Table 1. Biological activities reported for the isoflavonoids isolated from Iris germanica.Compound Bioactivity ReferenceGermanaism A (1) Cytotoxic activity IC50 = 43.9 \u00b1 1.5 \u00b5M (MTT); 4.5 \u00b1 0.4 \u00b5M (ATP) [34]Tectoridin (9) Free-radical scavenger, antioxidant, anti-inflammatory, antiproliferative,oestrogenic, anti-alcohol injury, hepatoprotective effects [48]Iridin (10) Potent anti-inflammatory effects (induced paw edema test) [24]Iridin A (11) High antioxidant activity;\u03b1-amylase inhibitory activity [38,40]Irisolidone 7-O-\u03b2-D-glucopyranoside (14) CyP1A inhibitor; QR inhibitor; DPPH scavengerIrilone (17)Cytotoxic activity IC50 = 47.7 \u00b1 3.5 \u00b5M (MTT), 17.7 \u00b1 1.4 \u00b5M (ATP);potent anti-inflammatory effects (induced paw edema test):high antioxidant activity;\u03b1-amylase inhibitory activity;potent inhibitor of cytochrome P450 1A activity (IC50 = 0.3 \u00b1 0.1 \u00b5M);immunomodulatory activity; CyP1A inhibitor; moderate QR inhibitor;DPPH scavenger[34][24][38,40][42][43]Irilone 4\u2032-O-\u03b2-D-glucopyranoside (19) Potent anti-inflammatory effects (induced paw edema test) [24]8-Hydroxyirilone (21) High antioxidant activity; \u03b1-amylase inhibitory activity [38,40]8-Hydroxyirilone 5-methyl ether (22) High antioxidant activity;\u03b1-amylase inhibitory activity [38,40]Iriflogenin (23) Potent inhibitor of cytochrome P450 1A activity (IC50 = 1.4 \u00b1 0.6 \u00b5M);CyP1A inhibitor; weak DPPH scavenger [42]Irifloside (25) Cytotoxic activity IC50 = 21.5 \u00b1 4.4 \u00b5M (MTT); 19.4 \u00b1 1.3 \u00b5M (ATP) [34]Irisolone (nigricin) (28) High anti-inflammatory activity [14]Nigricanin (iriskashmirianin) (29) CyP1A inhibitor; moderate QR inhibitor; weak DPPH scavenger [42]Iriskashmirianin A (30) Cytotoxic activity IC50 = 20.9 \u00b1 2.7 \u00b5M (MTT); 4.3 \u00b1 0.9 \u00b5M (ATP) [34]5,7-Dihydroxy-3-(3\u2032-hydroxy-4\u2032,5\u2032-dimethoxy)-8-methoxy-4H-1-benzopyran-4-one(33)Significant anti-inflammatory activity [14]Tectorigenin (35)Antifungal, free radical scavenger, antioxidant, anti-inflammatory,anti-angiogenic, antiproliferative, antineoplastic, hypoglycaemic,oestrogenic, hepatoprotectiv, antithrombotic, cardiovascular, anti-alcoholinjury activities;in patented pharmaceutical compositions for the treatment ofhormone-related diseases[48,49]Irigenin (37)Potent anti-inflammatory effects (induced paw edema test and inhibitionagainst superoxide); \u03b1-amylase inhibitory activity; potent inhibitor ofcytochrome P450 1A activity (IC50 = 1.2 \u00b1 0.3 \u00b5M); CyP1A inhibitor;moderate QR inhibitor, DPPH scavenger[14,24][38,40][42]Irigenin S (38) Potent anti-inflammatory effects (induced paw edema test) [24]Irisolidone (42)Potent anti-inflammatory effects (induced paw edema test);\u03b1-amylase inhibitory activity; immunomodulatory activity; CyP1Ainhibitor; QR inhibitor; DPPH scavenger; antiproliferative activityagainst amelanotic melanoma and large lung carcinoma cells; antioxidantproperties[24][38,40][43][50][51]Iristectorigenin A (43) Weak anti-inflammatory activity [14]Molecules 2021, 26, 264 6 of 21Table 1. Cont.Compound Bioactivity ReferenceIsoflavone (44) Moderate anti-inflammatory activity [14]5,7,8-Trihydroxy-3-(4-methoxyphenyl)-2-methyl-4H-chromen-4-one(47)Significant inhibition of TRAP in NF-kB ligand-induced osteoclasticRAW 264.7 cells (66.67 \u00b1 2.71%) [47]6,7-Dihydroxy-3-(4-methoxyphenyl)-2-methyl-4H-chromen-4-one(48)Significant inhibition of TRAP in NF-kB ligand-induced osteoclasticRAW 264.7 cells (57.32 \u00b1 2.46%) [47]Other FlavonoidsCompared to isoflavonoids, representative compounds of other flavonoid classesoccur less frequently in the extracts of I. germanica. Isolated flavanones (Figure 3) are narin-genin (49) [35] and 5,7,2\u2032-trihydroxy-6-methoxyflavanone (50) [31], whereas flavanonolsinclude dihydroquercetin-7,3\u2032-dimethylether (51) [45], dihydroquercetin-7,4\u2032-dimethylether(52) [35], and dihydroquercetin-7,3\u2032-dimethylether-5-O-\u03b2-D-glucopyranoside (53) [35].Flavones are represented by the O-glucoside cirsiliol-4\u2032-O-glucopyranoside (54) [35] andthe C-diglucoside PID (55) [52,53]. Flavonols and flavan-3-ols include ombuin (56) [35] and5,2\u2032-dihydroxy-3-methoxy-6,7-methylenedioxyflavone (57) [31], and (+)-(2R,3S)-catechin(58) [22], respectively. The anthocyanin delphanin (delphinidin-3-(4-p-coumaroylrhamnosyl-(1\u21926)-glucoside)-5-glucoside) (59) was isolated from flowers of I. germanica [54].Molecules 2021, 26, x FOR PEER REVIEW 6 of 22 Isoflavone 44 Moderate anti-inflammatory activity [14] 5,7,8-Trihydroxy-3-(4-methoxyphenyl)-2-methyl-4H-chromen-4-one (47) Significant inhibition of TRAP in NF-kB lig d duced ost oclastic RAW 264.7 cells (66.67 \u00b1 2.71%) [47] 6,7-Dihydroxy-3-(4-methoxyphenyl)-2-methyl-4H-chromen-4-one (48) Significant inhibition of TRAP in NF-kB ligand-induced osteoclastic RAW 264.7 cells (57.32 \u00b1 2.46%) [47] Other Flavonoids Compared to isoflavonoids, representative compounds of other flavonoid classes oc-cur less frequently in the extracts of I. germanica. Isolated flavanones (Figure 3) are naringenin (49) [35] and 5,7,2\u2032-trihydroxy-6-methoxyflavanone (50) [31], whereas fla-vanonols include dihydroquercetin-7,3\u2032-dimethylether (51) [45], dihydroquercetin-7,4\u2032-di-methylether (52) [35], an dihydroquercetin-7,3\u2032-dimethylether-5-O-\u03b2-D-gluc pyranoside (53) [35]. Flavones are represented by the O-glucoside cirsiliol-4\u2032-O-glucopyranoside (54) [35] and the C-diglucoside PID (55) [52,53]. Flavonols and flavan-3-ols include ombuin (56) [35] and 5,2\u2032-dihydroxy-3-methoxy-6,7-methylenedioxyflavone (57) [31], and (+)-(2R,3S)-catechin (58) [22], espectiv ly. The anthocyanin elphanin (delphinidin-3-(4-pcoumaroylrhamnosyl-(1\u21926)-glucoside)-5-gluc side) (59) was solated from flowers f I. germanica [54]. Figure 3. Characteristic flavonoids other than isoflavones isolated from Iris germanica. Miscellaneous Aromatic Compounds Other aromatic compounds (Figure 4) isolated from I. germanica include the C-gluco-sylxanthones mangiferin (60) [35] and irisxanthone (61) [35]; the phenol derivatives 2,4\u2032,6-trihydroxy-4-methoxybenzophenone-2-O-\u03b2-D-glucoside (62) [35], 1-(2-(6\u2032-hydroxy-2\u2032-methylcyclohex-1\u2032-enyloxy)-5-methoxyphenyl)ethanone (63) [23,44], isopeonol (64) [43], Figure 3. Characteristic flavonoids other than isoflavones isolated from Iris germanica.Miscellaneous Aromatic CompoundsOther aromatic compounds (Figure 4) isolated from I. germanica include the C-glucosylxanthonesmangiferin (60) [35] and irisxanthone (61) [35]; the phenol derivatives 2,4\u2032,6-trihydroxy-4-methoxybenzophenone-2-O-\u03b2-D-glucoside (62) [35], 1-(2-(6\u2032 \u2032 methylcyclohex-Molecules 2021, 26, 264 7 of 211\u2032-enyloxy)-5-methoxyphenyl)ethanone (63) [23,44], isopeonol (64) [43], acetovanillone(65) [15,23,35,37,44,46], androsin (66) [35], and 3-hydroxy-5-methoxyacetophenone (67) [24];the alkaloids 1,2,3,4-tetrahydro-\u03b2-carboline-3-carboxylic acid (68) [55] and the correspond-ing (S)-(\u2013)-methyl ester [55], (1S,3R)-methyl 1-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate (69) [55], methyl (1R,3R)-1-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate (70) [55], 4-(9H-\u03b2-carbolin-1-yl)-4-oxobut-2-enoic acid methyl ester(71) [55], 2-(furan-2-yl)-5-(2,3,4-trihydroxybutyl)-1,4-diazine (crotonine) (72) [55], 3-\u03b2-D-ribofuranosyluracil (uridine) [55], 6-hydroxymethyl-3-pyridinol (73) [55], and 2-amino-1H-imidazo-[4,5-b]pyrazine (74) [55]; the benzoic and cinnamic acid derivatives pyroglutamicacid [35], protocatechuic acid (75) [22], chlorogenic acid (76) [22], caffeic acid (77) [22], fer-ulic acid (78) [22], and p-hydroxy benzoic acid [22]. Crotonine (72) showed good analgesicactivity in vivo [55].Molecules 2021, 26, x FOR PEER REVIEW 7 of 22 acetovanillone (65) [15,2 ,35,37,4 ,46], androsin (66) [ 5], and 3-hydroxy-5-methoxyacetophenone (67) [24]; the alkaloids 1,2,3,4-tetrahydro-\u03b2-carboline-3-carboxylic acid (68) [55] and the corresponding (S)-(\u2013)-methyl ester [55], (1S,3R)-methyl 1-met l-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate (69) [55], methyl (1R,3R)-1-methyl-2,3,4,9-tetrahy ro-1H-pyrido[3,4-b]indole-3-carboxylate (70) [55], 4-(9H-\u03b2-carbolin-1-yl)-4-oxobut-2-enoic cid methyl ester (71) [55], 2-(furan-2-yl)-5-(2,3,4-trihydroxybutyl)-1,4-diazi e (crotonine) (72) [55], 3-\u03b2 D-rib furanosyluracil (uridine) [55], 6-hydroxymethyl-3-pyridinol (73) [55], and 2-amino-1H-imidazo-[4,5-b]pyrazine (74) [55]; the benzoic and cinnamic acid derivatives pyroglutamic acid [35], protocatechuic acid (75) [22], chlorogenic acid (76) [22], caffeic acid (77) [22], ferulic acid (78) [22], and p-hydr xy benzoic acid [22]. Crotonine (72) showed good analgesic activity in vivo [55]. Figure 4. Miscellaneous aromatic compounds isolated from Iris germanica. Terpenoids In addition to \u03b1- and \u03b2-amyrin [37], the most widespread triterpenoids occurring in I. germanica are iridals (Figure 5) [56]. These bitter tasting terpenoids can be isolated in appreciable amounts from the unsaponifiable fraction of lipid extracts from the rhizomes. Characteristic features of all iridals are a multi-substituted cyclohexane ring with a long side chain at C-11 (squalene numbering), an acrolein group at C-7, and a hydroxypropyl chain at C-6. The latter two substitutions are typical fragments of a seco A-ring of triterpe-noids. Appropriate labeling experiments have shown that 2,3-epoxysqualene is the pre-cursor of the iridals and that a bicyclic intermediate is possibly formed in the biosynthetic pathway, the A ring of which is subsequently opened to give the iridal skeleton [56]. Other labeling experiments have also proved the involvement of activated methionine for the introduction of the extra methyl group at C-22 of an open-chain precursor of methylated cycloiridals and irones [56]. The large group of iridals isolated from I. germanica include Figure 4. Miscellaneous aromatic compounds isolated from Iris germanica.TerpenoidsI addition to \u03b1- and \u03b2-amyrin [37], the most widespread t iterpenoids occurring inI. germanica are iridals (Figure 5) [56]. These bitter tasting terpenoids can be isolated inappreciable amounts from the unsap nifiabl fraction f lipid extracts from the rhizomes.Characteristic featur s of all iridals are a multi-substituted cyclohexane ring with a longside chain at C-11 (squale e numbering), an acrolein group at C-7, and a hydroxypropylchain at C-6. The latter two substitutions are typical fragments of a seco A-ring of triter-penoids. Appropriate labeling experiments have shown that 2,3-epoxysqualene is theprecursor of the iridals and that a bicyclic inter ediate is possibly formed in the biosyn-thetic pathway, the A ring of which is subsequently opened to give the iridal skeleton [56].Other labeling experiments have also proved the involvement of activated methionine forthe introduction of the extra methyl group at C-22 of an open-chain precursor of methy-lated cycloiridals and irones [56]. The large group of iridals isolated from I. germanicaMolecules 2021, 26, 264 8 of 21include iridal (79) [57\u201360], iridogermanal (80) [61], isoiridogermanal (81) [60,62,63], 16-O-acetylisoiridogermanal (82) [59,60,62], irisgermanical A (83) [60,62], irisgermanical B(84) [60,62], irisgermanical C (85) [60,62,63], iriflorental (86) [59,60,62,63], \u03b1-irigermanal(87) [59\u201363], iripallidal (88) [60,62,63], \u03b3-irigermanal (89) [29,59\u201363], compound 90 [63],\u03b1-dehydroirigermanal (91) [60,62,63], irigermanone (92) [63], iridobelamal A (93) [63],iristectorone K (94) [64], 29-acetoxyspiroiridal (95) [59]. Compound 79 showed potentantimalarial activity both in vitro and in vivo [57]. Compounds 79, 82, 86, 87, 89, and 95exhibited significant cytotoxicity against K562 leukema and A2780 ovarian cell lines [59].Compounds 86, 88 and 89 showed potent piscicidal activities at a concentration of lessthan 1 \u00b5g/mL of median tolerance limit (TLm) value [60,62], and compound 89 exhibitedsignificant antiulcer activity [29,65].olecules 2021, 26, x FOR PEER REVIEW 8 of 22 iridal (79) [57\u201360], iridogermanal (80) [61], isoiridogermanal (81) [60,62,63], 16-O-acetyli-soiridogermanal (82) [59,60,62], irisgermanical A (83) [60,62], irisgermanical B (84) [60,62], irisgermanical C (85) [60,62,63], iriflorental (86) [59,60,62,63], \u03b1-irigermanal (87) [59\u201363], iripallidal (88) [60,62,63], \u03b3-irigermanal (89) [29,59\u201363], compound 90 [63], \u03b1-dehy-droirigermanal (91) [60,62,63], irigermanone (92) [63], iridobelamal A (93) [63], iristectorone K (94) [64], 29-acetoxyspiroiridal (95) [59]. Compound 79 showed potent an-timalarial activity both in vitro and in vivo [57]. Compounds 79, 82, 86, 87, 89, and 95 exhibited significant cytotoxicity against K562 leukema and A2780 ovarian cell lines [59]. Compounds 86, 88 and 89 sho ed potent piscicidal activities at a concentration of less than 1 \u03bcg/mL of median tolerance limit (TLm) value [60,62], and compound 89 exhibited significant antiulcer activity [29,65]. Figure 5. Iridals isolated from Iris germanica. \u03b1- (96), \u03b2- (97), and \u03b3-Irone (98) (Figure 6) are the odoriferous principle of iris oils. It is well known that freshly harvested iris rhizomes do not contain irones, but their triterpe-noid precursors iridals (Figure 5). According to the traditional procedure, decorticated rhizomes of some Iris species (e.g., I. germanica, I. pallida, I. florentina) are kept in a dry and aerated environment for 2\u20133 years, then powdered, incubated with diluted sulphuric acid, and steam-distilled to provide the precious \u201corris butter\u201d. The mechanism of the oxidative Figure 5. Iridals isolated from Iris germanica.\u03b1- (96), \u03b2- (97), and \u03b3-Irone (98) (Figure 6) are the odoriferous principle of iris oils. It iswell known that freshly harvested iris rhizomes do not contain irones, but their triterpenoidprecursors iridals (Figure 5). According to the traditional procedure, decorticated rhizomesof some Iris species (e.g., I. germanica, I. pallida, I. florentina) are kept in a dry and aeratedenvironment for 2\u20133 years, then powdered, incubated with diluted sulphuric acid, andsteam-distilled to provide the precious \u201corris butter\u201d. The mechanism of the oxidativedegradation affording irones from iridals is still poorly understood. The traditional processMolecules 2021, 26, 264 9 of 21is long, troublesome and low yielding; hence, the high cost of the essence (butter). Purifica-tion of the essence eliminates the fatty acids and yields the absolute, which is sold at severalthousands of dollars per kilogram [10]. It has been established that the distribution ofirone isomers and enantiomers in different qualities of iris oils depends upon the botanicalspecies of the plant [44]. Thus, the average composition of an iris butter prepared fromIris germanica is the following: 0.91% of (+)-trans-\u03b1-irone (ee = 96%, (+)-96a), 61.48% of(\u2212)-cis-\u03b1-irone (ee = 82%, (\u2212)-96b), 0.71% of \u03b2-irone (97) and 37.60% of (\u2212)-cis-\u03b3-irone (ee= 38%, (\u2212)-98) [10]. Irone-related compounds 99\u2013118 (Figure 6) are also occurring in theessential oil [66].Molecules 2021, 26, x FOR PEER REVIEW 9 of 22 degradation affording irones from iridals is still poorly understood. The traditional pro-cess is long, troublesome and low yielding; hence, the high cost of the essence (butter). Purification of the essence eliminates the fatty acids and yields the absolute, which is sold at several thousands of dollars per kilogram [10]. It has been established that the distribu-tion of irone isomers and enantiomers in different qualities of iris oils depends upon the botanical species of the plant [44]. Thus, the average composition of an iris butter prepared from Iris germanica is the following: 0.91% of (+)-trans-\u03b1-irone (ee = 96%, (+)-96a), 61.48% of (\u2212)-cis-\u03b1-irone (ee = 82%, (\u2212)-96b), 0.71% of \u03b2-irone (97) and 37.60% of (\u2212)-cis-\u03b3-irone (ee = 38%, (\u2212)-98) [10]. Irone-related compounds 99\u2013118 (Figure 6) are also occurring in the essential oil [66]. Figure 6. Irones and irone-related compounds isolated from Iris germanica. Steroids and Miscellaneous Compounds Common sterols isolated from I. germanica include: cholesterol [67], campesterol [67], sitosterol [37,67], \u03b2-sitosterol [35], daucosterol [35], stigmasterol [24,67], and stigmasterol-3-O-\u03b2-D-glucopyranoside [24]. Compounds of different biogenetic origin (Figure 7) in-clude iriside A (96) [24], irisamides A (97) [41], irisamides B (98) [41], 6,6-ditetradecyl-6,7-dihydrooxepin-2(3H)-one (102) [23], 2-acetoxy-3,6-dimethoxy-1,4-benzoquinone (108) [23]. Compounds 97 and 98 were reported to be active against L5178Y and Hela tumor cell lines [41]. Figure 7. Miscellaneous compounds isolated from Iris germanica. . - l t s is late fro Iris ger anica.Steroids and Miscellaneous CompoundsCommon sterols isolated from I. germanica include: cholesterol [67], campesterol [67],sitosterol [37,67], \u03b2-sitosterol [35], daucosterol [35], stigmasterol [24,67], and stigmasterol-3-O-\u03b2-D-glucopyranoside [24]. Compounds of different biogenetic origin (Figure 7) in-clude iriside A (96) [24], irisamides A (97) [41], irisamides B (98) [41], 6,6-ditetradecyl-6,7-dihydrooxepin-2(3H)-one (102) [23], 2-acetoxy-3,6-dimethoxy-1,4-benzoquinone (108) [23].Compounds 97 and 98 were reported to be active against L5178Y and Hela tumor celllines [41].Molecules 2021, 26, x FOR PEER REVIEW 9 of 22 degradation affording irones from iridals is still poorly understood. The traditional pro-cess is long, troublesome and low yielding; hence, the high cost of the essence (butter). Purification of the essence eliminates the fatty acids and yields the absolute, which is sold at several thousands of dollars per kilogram [10]. It has been established that the distribu-tion of irone isomers and enantio ers in different qualities of iris oils depends upon the botanical species of the plant [44]. Thus, the average composition of an iris butter prepared from Iris germanica is the following: 0.91% of (+)-trans-\u03b1-irone (ee = 96%, (+)-96a), 61.48% of (\u2212)-cis-\u03b1-irone (ee = 82%, (\u2212)-96b), 0.71% of \u03b2-irone (97) and 37.60 of (\u2212)-cis-\u03b3-irone (ee = 38%, (\u2212)-98) [10]. Irone-related compounds 99\u2013118 (Figure 6) are also occurring i the essential oil [66]. Figure 6. Irones and irone-related compounds isolated from Iris germanica. Steroids and Miscellaneous Compounds Common sterols isolated from I. germanica include: cholesterol [67], campesterol [67], sitosterol [37,67], \u03b2-sitosterol [35], daucosterol [35], stigmasterol [24,67], and stigmasterol-3-O-\u03b2-D-glucopyranoside [24]. Compounds of different biogenetic origin (Figure 7) in-clude iriside A (96) [24], irisamides A (97) [41], irisamides B (98) [41], 6,6-ditetradecyl-6,7-dihydrooxepin-2(3H)-one (102) [23], 2-acetoxy-3,6-dimethoxy-1,4-benzoquinone (108) [23]. Compounds 97 and 98 were reported to be active against L5178Y and Hela tumor cell lines [41]. Figure 7. Miscellaneous compounds isolated from Iris germanica. Fig re 7. isce laneous co pounds isolate fr Iris er ic .2.1.2. Iris persicaI. persica is used to treat tumors and wound inflammation in the traditional medicineof Kurdistan [5]. Essential oils obtained by hydrodistillation of air-dried flowers, leaves,rhizomes, and fresh bulbs were investigated by GC\u2013FID and GC\u2013MS; moreover, the oilantifungal activities were determined [12]. The major constituents of the flower essentialoil were phenylethanol (24.8%) and furfural (13.8%). This aldehyde was also the mainMolecules 2021, 26, 264 10 of 21component of the leaf and rhizome volatile fractions, with percentages of 39.0% and 22.2%,respectively. Phenylacetaldehyde (37.1%) was the main constituent of the volatile fractionfrom the bulbs. The oils exhibited moderate antifungal activity in vitro against strains ofthe human pathogenic fungi Candida albicans, Microsporum canis, and Trichophyton menta-grophytes, the plant\u2013fungal pathogen Pyricularia oryzae, and the fungal food contaminantAspergillus carbonarius. The highest activity was exhibited by the essential oils isolated fromleaves and flowers, so that they could be considered natural antimicrobial agents.A few known bioactive flavonoids (Figure 8) were abundant in the non-volatileextracts of the plant. Thus, the C-diglucoside flavone embinin (55) was isolated fromflowers and leaves, the 6-C-glucoside flavone isovitexin (109) was isolated from flowers,the stilbenoid (\u2212)-trans-resveratrol-3-O-\u03b2-D-glucopyranoside (110) was found in rhizomes,and the isoflavone (+)-tectorigenin (35) was isolated from bulbs [13]. In an MTT assay,embinin (55) showed a significant inhibitory activity that was higher than the well-knownantitumor drug cisplatin, against MCF7, SkBr3, Ishikawa, BG-1, and A549 human tumorcells. Moreover, embinin showed a remarkable DPPH radical scavenging activity, that wascomparable to that of the well-known antioxidant ascorbic acid [13].Molecules 2021, 26, x FOR PEER REVIEW 10 of 22 2.1.2. Iris persica I. persica is used to treat tumors and wound inflammation in the traditional medicine of Kurdistan [5]. Essential oils obtained by hydrodistillation of air-dried flowers, leaves, rhizomes, and fresh bulbs were investigated by GC\u2013FID and GC\u2013MS; moreover, the oil antifungal activities were determined [12]. The major constituents of the flower essential oil were phenylethanol (24.8%) and furfural (13.8%). This aldehyde was also the main component of the leaf and rhizome volatile fractions, with percentages of 39.0% and 22.2%, respectively. Phenylacetaldehyde (37.1%) was the main constituent of the volatile fraction from the bulbs. The oils exhibited moderate antifungal activity in vitro against strains of the human pathogenic fungi Candida albicans, Microsporum canis, and Tri-chophyton mentagrophytes, the plant\u2013fungal pathogen Pyricularia oryzae, and the fungal food contaminant Aspergillus carbonarius. The highest activity was exhibited by the essen-tial oils isolated from leaves and flowers, so that they could be considered natural antimi-crobial agents. fe known bioactive flavonoids (Figure 8) were abundant in the non-volatile ex-tracts of the plant. Thus, the C-diglucoside flavone embinin (55) was isolated from flowers and l aves, the 6-C-glucoside flavone iso itexin (109) was isolated fr m flowers, the stil-benoid (\u2212)-trans-resveratrol-3-O-\u03b2-D-glucopyranoside (110) was found in rhizomes, and the isoflav ne (+)-tectorigenin (35) was isol ted from bulbs [13]. In an MTT ssay, embinin (55) showed a significant inhibitory activity that was higher than the well-known anti-tumor drug cisplatin, against MCF7, SkBr3, Ishikawa, BG-1, and A549 human tumor cells. Moreove , embinin showed a remark ble DPPH radical scavenging activity, that OOHOOHOHOOHHO OHHO109OHOHOOOHHO OHHO110 Figure 8. Characteristic phenolic compounds isolated from Iris persica. 2.2. Phytochemical Studies on Iris postii A decoction of the aerial parts of Iris postii Mouterde is used in the Iraqi folkloric medicine as a general remedy against inflammations. The plant, which is native to Middle East, grows wildly on the slopes of Mount Korek (Figure 9), a mountain located in the Erbil province not far from the Iranian border, where it was collected for this investiga-tion. Figure 9. Iris postii and Korek mountain where the plant was collected (photos taken by H.I.M.A.). i re 8. aracteristic e lic c s is late fr Iris persica.2.2. Phytochemical Studies on Iris postiiA decoction of the aerial parts of Iris postii Mouterde is used in the Iraqi folkloricmedicine as a general remedy against inflammations. The plant, which is native to MiddleEast, grows wildly on the slopes of Mount Korek (Figure 9), a mountain located in the Erbilprovince not far from the Iranian border, where it was collected for this investigation.Molecules 2021, 26, x FOR PEER REVIEW 10 of 22 2.1.2. Iris persica I. persica s used to treat tumors and wound inflammation in the traditional medicine of Kurdistan [5]. Essential oils obtained by hydrodistillation of air-dried flowers, leaves, rhizomes, and fresh bulbs were investigated by GC\u2013FID and GC\u2013MS; moreover, the oil antifungal activities were determined [12]. The major constituents of the flower essential oil were phenylethanol (24.8%) and furfural (13.8%). This aldehyde was also the main component of the leaf and rhizome volatile fractions, with percentages of 39.0% and 22.2%, respectively. Phenylacetaldehyde (37.1%) was the main constituent of the volatile fraction from the bulbs. The oils exhibited moderate antifungal activity in vitro against strains of the human pathogenic fungi Candida albicans, Microsporum canis, and Tri-chophyton mentagrophytes, the plant\u2013fungal pathogen Pyricularia oryzae, and the fungal food contaminant Aspergillus carbonarius. The highest activity was exhibited by the essen-tial oils isolated from leaves and flowers, so that they could be considered natural antimi-crobial agents. A few known bioactive flavonoids (Figure 8) were abundant in the non-volatile ex-tracts of the plant. Thus, the C-diglucoside flavone embinin (55) was isolated from flowers and leaves, the 6-C-glucoside flavone isovitexin (109) was isolated from flowers, the stil-benoid (\u2212)-trans-resveratrol-3-O-\u03b2-D-glucopyranoside (110) was found in rhizomes, and the isoflavone (+)-tectorigenin (35) was isolated from bulbs [13]. In an MTT assay, embinin (55) showed a significant inhibitory activity that was higher than the well-known anti-tumor drug cisplatin, against MCF7, SkBr3, Ishikawa, BG-1, and A549 human tumor cells. Moreover, embinin showed a remarkable DPPH radical scavenging activity, that was comparable to that of the well-known antioxidant ascorbic acid [13]. OOHOOHOHOOHHO OHHO109OHOHOOOHHO OHHO110 Figure 8. Characteristic phenolic compounds isolated from Iris persica. 2.2. Phytochemical Studies on Iris postii A de oction of the aerial parts of Iris postii Mouterde is used in the Iraqi folkloric medicine as a general remedy against inflammations. The plant, which is native to Middle East, grows wildly on the slopes of Mount Korek (Figure 9), a mountain located in the Erbil province not far from the Iranian border, where it was collected for this investiga-tion. Figure 9. Iris postii and Korek mountain where the plant was collected (photos taken by H.I.M.A.). Figur . is postii and Korek mountain wher the plant was collected (phot s taken by H.I.M.A.).Neither phytochemical investigations nor evaluations of biological activities have beencarried out on extracts of I. postii so far. Therefore, on the assumption that the bioactivitymostly resided in polar metabolites, we decided to examine the phytochemical contentsand the antioxidant properties of polar extracts of the aerial parts and rhizomes.At first, powdered aerial parts and rhizomes were separately defatted by soaking inhexane at room temperature; most chlorophyll was also removed in this manner. Succes-sively, each biomass was extracted with MeOH. The yields of the residues, IPA from theaerial parts and IPR from the rhizomes, were 1.3 and 2.75% (w/w), respectively. Succes-sively, IPA and IPR were separately partitioned between H2O and dichloromethane andMolecules 2021, 26, 264 11 of 21H2O and n-butanol, respectively, to give fractions IPAD and IPRB, respectively. Multiplemedium-pressure liquid chromatographic separations of a sample of IPAD on reversed-phase (RP-18) columns afforded L-tryptophan, androsin (66), apigenin 6-C-glucoside(isovitexin) (109), swertisin (111), and 2\u201d-O-rhamnosyl swertisin (112). Analogous chro-matographic separations of a sample of IPRB gave trans-\u03b5-viniferin (113), trans-resveratrol3,4\u2032-O-diglucoside (114), and isotectorigenin (115). The structures of isolated compounds(Figure 10) were established mainly by extensive 1D- and 2D-NMR experiments and MSspectrometry. Comparing our spectroscopic data with the pertinent literature, we foundsome differences between our data and those reported from different laboratories, especiallyfor the NMR signals of swertisin (111) [68\u201373] and 2\u201d-O-rhamnosylswertisin (112) [71,74];moreover, literature data are often not consistent between each other and some spectrahave been recorded in solvents different from those used in this work. Therefore, althoughthe isolated compounds are known, the physical and spectroscopic data determined byus are reported in the Experimental section, whereas the graphics are included in theSupplementary Materials.Molecules 2021, 26, x FOR PEER REVIEW 11 of 22 Neither phytochemical investigations nor evaluations of biological activities have been carried out on extracts of I. postii so far. Therefore, on the assumption that the bioac-tivity mostly resided in polar metabolites, we decided to examine the phytochemical con-tents and the antioxidant properties of polar extracts of the aerial parts and rhizomes. At first, powdered aerial parts and rhizomes were separately defatted by soaking in hexane at room temperature; most chlorophyll was also removed in this manner. Succes-sively, each biomass was extracted with MeOH. The yields of the residues, IPA from the aerial parts and IPR from the rhizomes, were 1.3 and 2.75% (w/w), respectively. Succes-sively, IPA and IPR were separately partitioned between H2O and dichloromethane and H2O and n-butanol, respectively, to give fractions IPAD and IPRB, respectively. Multiple medium-pressure liquid chromatographic separations of a sample of IPAD on reversed-phase (RP-18) columns afforded L-tryptophan, androsin (66), apigenin 6-C-glucoside (iso-vitexin) (109), swertisin (111), and 2\u2032\u2032-O-rhamnosyl swertisin (112). Analogous chromato-graphic separations of a sample of IPRB gave trans-\u03b5-viniferin (113), trans-resveratrol 3,4\u2032-O-diglucoside (114), and isotectorigenin (115). The structures of isolated compounds (Fig-ure 10) were established mainly by extensive 1D- and 2D-NMR experiments and MS spec-trometry. Comparing our spectroscopic data with the pertinent literature, we found some differences between our data and those reported from different laboratories, especially for the NMR signals of swertisin (111) [68\u201373] and 2\u2032\u2032-O-rhamnosylswertisin (112) [71,74]; moreover, literature data are often not consistent between each other and some spectra have been recorded in solvents different from those used in this work. Therefore, although the isolated compounds are known, the physical and spectroscopic data determined by us are reported in the Experimental section, whereas the graphics are included in the Sup-plementary Materials. Figure 10. Structures of swertisin (111), 2\u2032\u2032-O-rhamnosyl swertisin (112), viniferin (113), resveratrol 3,4\u2032-O-di-\u03b2-D-glucopyranoside (114), isotectorigenin (115) isolated from Iris postii Mouterde; H\u2192C HMBC correlations determined in the 2D-NMR spectrum of 2\u2032\u2032-O-rhamnosyl swertisin (112A). It is now generally accepted by scientists that excess oxidants and radicals, especially oxygen radicals, through damage and mutation of DNA and other biomolecules, play a major role in degenerative processes that may cause the insurgence and progression of inflammatory processes, cancer, cardiovascular and atherosclerotic diseases, neurodegen-eration, and aging [75,76]. Antioxidants isolated from natural sources could thus become important chemotherapeutic agents in defense mechanisms against these toxic agents. Therefore, with the aim to give some scientific evidence to the traditional use of I. postii in the treatment of inflammations and in search of a new source of natural antioxidants, two simple tests were performed in vitro to determine the total antioxidant capacity (TAOC) of the crude extracts (see text) and the antiradical activity of the extracts and the isolated compounds. The TAOC values of the extracts were determined by the phosphomolybdate Figure 10. Structures of swertisin (111), 2\u201d-O-rhamnosyl swertisin (112), viniferin (113), resveratrol3,4\u2032-O-di-\u03b2-D-glucopyranoside ( 14), isotectorigenin ( 15) isolated from Iris postii Mouterde; H\u2192CH BC co relations deter ined in the 2 - spectr f 2\u201d- -rha nosyl s ertisi (112 ).It is now generally accepted by scientists that excess oxidants and radicals, especiallyoxygen radicals, through damage and mutation of DNA and other biomolecules, play amajor role in degenerative processes that may cause the insurgence and progression ofinflammatory processes, cancer, cardiovascular and atherosclerotic diseases, neurodegener-ation, and aging [75,76]. Antioxidants isolated from natural sources could thus becomeimportant chemotherapeutic agents in defense mechanisms against these toxic agents.Therefore, with the aim to give some scientific evidence to the traditional use of I. postii inthe treatment of inflammations and in search of a new source of natural antioxidants, twosimple tests were performed in vitro to determine the total antioxidant capacity (TAOC)of the crude extracts (see text) and the antiradical activity of the extracts and the isolatedcompounds. The TAOC values of the extracts were determined by the phosphomolybdatemethod (adjusted from references [77\u201379]), using ascorbic acid as the standard. The assaywas based on the reduction of hexavalent molybdenum Mo (VI) to the pentavalent form[Mo (V)] by an antioxidant, and the formation of a green phosphate/Mo (V) complexat acidic pH and at high temperature. The TAOC values were expressed as \u00b5g ascorbicacid equivalent/mg extract (Table 2). The greater this value, the higher was the antioxi-dant capacity. Thus, the total methanol extract of the aerial parts (IPA) and the n-butanolsub-extract of the methanolic extract of the rhizomes (IPRB) exhibited the highest totalantioxidant activity. Moreover, comparing the TAOC of the IPA extract with that of thedichloromethane sub-extract (IPAD), it appears that highly antioxidant compounds, likelyvery polar, were not adequately extracted by CH2Cl2. Therefore, they need further study.Molecules 2021, 26, 264 12 of 21Table 2. Antiradical and antioxidant activities of extracts and compounds isolated from Iris postii.SampleDPPH Scavenging ActivityTotal Antioxidant Capacity (TAOC) bEC50 (\u00b5g/mL) EC50 (\u00b5M/L) AAE aAndrosin (66) 48.94 \u00b1 0.09 149.21 0.48 -Isovitexin (109) 50.97 \u00b1 1.11 117.99 0.46 -Swertisin (111) 37.35 \u00b1 0.13 83.74 0.63 -2\u201d-O-\u03b1-L-Rhamnosyl swertisin (112) 26.52 \u00b1 0.11 44.79 0.89 -\u03b5-Viniferin (113) 26.06 \u00b1 0.01 57.39 0.90 -Trans-resveratrol3,4\u2032-O-di-\u03b2-D-glucopyranoside (114) 22.91 \u00b1 0.05 41.50 1.03 -Isotectorigenin (115) 34.87 \u00b1 0.13 116.23 0.67 -Ascorbic acid 23.52 \u00b1 0.22 133.63 1.00 -IPA c 19.21 \u00b1 0.01 - 1.22 0.39IPAD d 62.79 \u00b1 0.03 - 0.37 0.21IPR e 46.28 \u00b1 0.12 - 0.51 0.29IPRB f 39.11 \u00b1 0.10 - 0.60 0.46a Expressed as \u00b5g ascorbic acid equivalents/\u00b5g sample; b expressed as \u00b5g ascorbic acid equivalents/\u00b5g extract; c methanol extract of aerialparts; d dichloromethane fraction from IPA; e methanol extract of rhizomes; f butanol fraction from IPR.Subsequently, the free radical scavenging (FRS) activity of the isolated compounds 66,109, 111\u2013115, the crude extracts and the standard ascorbic acid were determined using the2,2-diphenyl-1-picrylhydrazyl radical (DPPH) method (adjusted from references [78,79]).DPPH is a stable, nitrogen-centered free radical which produces violet/purple color inmethanol solution and fades to shades of yellow color in the presence of a hydrogenradical/electron-donor compound. The antiradical activity was expressed as EC50 value,i.e., the concentration (\u00b5g/mL) of the sample required to scavenge 50% of the initial DPPHconcentration and as \u00b5g ascorbic acid equivalents/\u00b5g sample. In the case of isolatedcompounds, the activity was also measured as EC50 (\u00b5M/L), which, in our opinion, is amore accurate measurement of the intrinsic antiradical activity of a compound. The resultsof the DPPH assay (Table 2) essentially confirmed those obtained by the molybdate test asfar as the antioxidant activity of the extracts is concerned. On the other hand, concerningthe DPPH scavenging activity of single compounds, 2\u201d-O-\u03b1-L-rhamnosyl- swertisin (112),\u03b5-viniferin (113), and resveratrol 3,4\u2032-O-di-\u03b2-D-glucopyranoside (114) were as effective asthe standard ascorbic acid or even more efficacious. The remaining isolated compounds,androsin (66), isovitexin (109), swertisin (111), and isotectorigenin (115), were moderatelyactive, although the EC50 values of compounds 109, 111 and 115, expressed as \u00b5M/L, werelower than that of ascorbic acid.3. Material and Methods3.1. General Experimental Techniques and ProceduresFor most general experimental techniques and procedures, see reference [80]; 1H-NMR and 13C-NMR chemical shifts (\u03b4, ppm) are relative to signals of residual CHD2ODin CD3OD \u03b4H 3.27 (central line of a quintuplet), 13CD3OD [\u03b4C 49.0 (central line of a septu-plet)], and 13C-4 of C5D5N [\u03b4C 134.3 (central line of a triplet)], respectively. All the NMRexperiments were performed on a Bruker AV300 spectrometer, at 300 (1H) and 75.47 MHz(13C), respectively. Deuterated solvents (purity 99.8%) were purchased from Sigma-Aldrich(St. Louis, MO, USA). ESI-MS experiments were carried out on a Thermo-TSQ massspectrometer, by flow injection analysis (FIA), with the electron-spray ionization source(ESI) at 5 kV on TIP capillary. Spectroscopy grade solvents (Sigma-Aldrich) were used.Molecules 2021, 26, 264 13 of 21Preparative medium-pressure liquid chromatographic (MPLC) separations were carriedout on a Biotage Isolera instrument (Biotage, Uppsala, Sweden).3.2. Plant MaterialAerial parts and rhizomes of I. postii Mouterde were separately collected on KorekMountain (GPS position: 36\u25e635\u203220\u201d N, 44\u25e627\u203232\u201d E). The plant was identified by botanist A.H. Al-khayyat of Salahaddin University-Erbil/Iraq. A voucher specimen (accession number7230) has been deposited at the Education Salahaddin University Herbarium (ESUH). Thevegetal materials were cleaned and air-dried under shade at room temperature (20\u201325 \u25e6C)in a ventilated room until they reached constant weight. After drying, each plant part wasfinely powdered using a laboratory grinding mill, and powdered materials were stored inbottles at room temperature until analyses.3.3. Extraction of I. postii and Chromatographic Fractionation of ExtractsPowdered aerial parts and rhizomes (200 g each) were separately soaked in hexane(800 mL) with occasional shaking in an ultrasonic bath for 20 min, then left in the samesolvent for 5 h under continuous stirring at room temperature. Subsequently, the mixturewas decanted and filtered. This procedure was repeated three times for each part. Defattedrhizomes and aerial parts were subsequently separately suspended in MeOH (800 mL) nan ultrasonic bath for 20 min and then left in the same solvent for 5 h under continuousstirring, at room temperature. The procedure was repeated three times for each vegetablepart. The mixtures were then filtered, and the solvent removed under vacuum in a rotaryevaporator to afford two crude residues: IPA (2.6 g) from aerial parts and IPR (5.5 g) fromrhizomes.Subsequently, IPA (2.5 g) was suspended in MeOH-H2O (75:25, 350 mL) and extractedwith CH2Cl2 (3 \u00d7 350 mL) to afford, upon evaporation, a dichloromethane soluble powder(1.9 g) (IPAD). Then, 500 mg of this residue was separated on a hand-packed reversed phasecolumn (LiChroprep RP18, 25\u201340 \u00b5m, 120 g, MerckMillipore, Darmstadt, Germany) usinga medium pressure liquid chromatographic (MPLC) instrument (Isolera ONE, Biotage,Uppsala, Sweden). Solvents A and B of the mobile phase were H2O and MeOH, respectively.A linear gradient was applied from a 70:30 A/B mixture to 100% solvent B (MeOH), over30 min at room temperature, at a flow rate of 30 mL/min; the detection UV wavelengthwas set at UV 254\u2013366 nm. Finally, the column was washed with 100% MeOH for 3 min toelute strongly adsorbed compounds. Forty-five fractions (20 mL each) were collected; thesolvent in the tubes was evaporated using a centrifuge under vacuum and a liquid nitrogentrap, and the residues were weighed. The overall recovery of the chromatographed mixturewas 95%. Then, the content of each fraction was analyzed by TLC on analytical silica gel 60(GF254, Merck, Darmstadt, Germany) plates, eluted with EtOAc/n-BuOH/HCO2H/H2O(5:3:1:1), and on RP-18 (Sigma-Aldrich) plates, eluted with MeOH/H2O (1:1). Spots weredetected under UV light at 254 and 366 nm and by spraying the plates with 0.5% vanillin insulfuric acid/EtOH (4:1), followed by heating at 105 \u25e6C for about 1 min. Repeated MPLCseparation of main fractions on reversed-phase columns afforded L-tryptophan (29 mg),androsin (66, 13 mg), apigenin 6-C-glucoside (isovitexin) (109, 45 mg), swertisin (111,17 mg), 2\u201d-O-rhamnosyl swertisin (112, 12 mg). A portion of IPR (5 g) was suspended in500 mL of water and partitioned with 500 mL of n-butanol to yield, after evaporation, 2.2 gof residue IPRB. Then, 1 g of this mixture was loaded onto a preparative RP-MPLC columninstalled in the MPLC instrument that was eluted with a gradient of 20\u2013100% MeOH inH2O for 2 h at a flow rate of 10 mL/min. Repeated MPLC chromatographic separationsof the main collected fractions on reversed-phase columns afforded trans-\u03b5-viniferin (113,9 mg), trans-resveratrol 3,4\u2032-O-diglucoside (114, 7 mg), and isotectorigenin (115, 21 mg).3.4. Spectroscopic Data of Isolated CompoundsAndrosin (4-O-\u03b2-D-glucopyranosyl-acetovanillone) (66): Colorless powder; TLC (sil-ica gel, DCM/MeOH, 8:2): Rf = 0.67; UV \u03bbmax (MeOH): 275, 308 nm; the molecular formulaMolecules 2021, 26, 264 14 of 21C15H20O8 was inferred from the [M + Na]+ ion peak at m/z 351.23 in the ESI-MS (positiveion mode) spectrum; 1H-NMR (300 MHz, CD3OD) \u03b4 7.67 (1H, dd, J = 8.5 and 1.9 Hz, H-6),7.60 (1H, d, J = 1.9 Hz, H-2), 7.25 (1H, d, = 8.5 Hz, H-5), 5.06 (1H, d, J = 7.2 Hz, H-1\u2032),3.92 (3H, s, OCH3), 3.89 (1H, dd, J = 12.0 and 1.7 Hz H-6\u2032b), 3.71 (1H, dd, J = 12.0 and5.2 Hz H-6\u2032a), 3.35\u20133.55 (4H, m, H-2\u2032,3\u2032,4\u2032,5\u2032), 2.59 (3H, s, COCH3); 13C-NMR (75 MHz,CD3OD): aglycone moiety: \u03b4C 133.2 (0, C-1), 112.7 (1, C-2), 150.9 (0, C-3), 152.8 (0, C-4),116.5 (1, C-5), 124.7 (1, C-6), 199.7 (0, C-7), 26.7 (3, C-8), 56.9 (3, OCH3); glucose moiety: \u03b4C102.1 (1, C-1\u2032), 75.0 (1, C-2\u2032), 78.7 (1, C-3\u2032), 71.5 (1, C-4\u2032), 78.2 (1, C-5\u2032), 62.8 (2, C-6\u2032). Thenumbers in parentheses are the protons attached to the corresponding carbon and weredetermined by DEPT experiments. The 1H and 13C-NMR spectra were in accordance withthe literature [81]. Acid hydrolysis (3% aqueous H2SO4, 80 \u25e6C, 2 h) provided D-glucose,identical by TLC and comparison of the optical rotation with an authentic sample.Isovitexin (apigenin 6-C-\u03b2-glucopyranoside or 4\u2032,5,7-trihydroxy-6-C-\u03b2-glucopyranoside)(109): Pale yellow powder; TLC (RP-18, MeOH/H2O, 6:4): Rf = 0.51; UV \u03bbmax (MeOH):270, 333 nm; the molecular formula C21H20O10 was determined from the [M + Na]+ ionpeak at m/z 455.22 in the ESI-MS (positive ion mode) spectrum and the [M \u2212 H]\u2212 ion peakat m/z 431.20 in the ESI-MS (negative ion mode) spectrum; 1H-NMR (300 MHz, CD3OD)aglycone moiety: \u03b4 7.83 (2H, d, J = 8.7 Hz, H-2\u2032 and H-6\u2032), 6.93 (2H, d, J = 8.7 Hz, H-3\u2032and H-5\u2032), 6.59 (1H, s, H-3), 6.50 (1H, s, H-8); glucose moiety: \u03b4 4.91 (1H, d, J = 10.0 Hz,H-1\u201d), 4.19 (1H, distorted t, H-2\u201d), 3.90 (1H, dd, J = 12.2 and 1.7 Hz, H-6\u201db), 3.75 (1H, dd,J = 12.0 and 5.0 Hz, H-6\u201da), 3.52\u20133.35 (3H, m, H-3\u201d,4\u201d,5\u201d); 13C-NMR (75 MHz, CD3OD)aglycone moiety: \u03b4C 184.0 (0, C-4), 166.1 (0, C-2), 164.9 (0, C-7), 162.8 (0, C-4\u2032), 162.0 (0,C-5), 158.7 (0, C-9), 129.4 (1 and 1, overlapped C-2\u2032 and C-6\u2032), 123.1 (0, C-1\u2032), 117.0 (1 and1, overlapped C-3\u2032 and C-5\u2032), 109.2 (0, C-6), 105.2 (0, C-10), 103.8 (1, C-3), 95.2 (1, C-8);glucose moiety: \u03b4C 82.6 (1, C-5\u201d), 80.1 (1, C-3\u201d), 75.2 (1, C-1\u201d), 72.6 (1, C-2\u201d), 71.8 (1, C-4\u201d),62.9 (2, C-6\u201d). The numbers in parentheses are the protons attached to the correspondingcarbon and were determined by DEPT experiments. The 1H- and 13C-NMR spectra were inaccordance with the literature [82]. No rotational isomerism was observed, in accordancewith references [68,83].Swertisin (4\u2032,5-dihydroxy-7-methoxyflavone-6-C-\u03b2-D-glucopyranoside) (111): Paleyellow powder; TLC (RP-18, MeOH/H2O, 6:4): Rf = 0.53; UV \u03bbmax (MeOH): 271, 332 nm;IR (nujol): 3360, 1650, 1605 cm\u22121; the molecular formula C22H22O10 was inferred from the[M + Na]+ ion peak at m/z 469.29 in the ESI-MS (positive ion mode) spectrum and the[M \u2212 H]\u2212 ion peak at m/z 445.30 in the ESI-MS (negative ion mode) spectrum; 1H-NMR(300 MHz, CD3OD) \u03b4 7.90 (2H, d, J = 8.6 Hz, H-2\u2032, 6\u2032), 6.94 (2H, d, J = 8.6 Hz, H-3\u2032, 5\u2032), 6.76(1H, s, H-8), 6.67 (1H, s, H-3), 4.87 (1H, d, J = 10.0 Hz, H-1\u201d), 4.35\u20134.48 and 4,15\u20134.27 (1Hoverall, 2 m, H-2\u201d of two rotamers), 3.96 (3H, s, OCH3), 3.80\u20133.95 (1H, m, H-6\u201db), 3.55\u20133.75(1H, m, H-6\u201da), 3.25-3.45 (3H, m, H-3\u201d, 4\u201d, 5\u201d); 13C-NMR (75 MHz, C5D5N) \u03b4C 181.8 (0,C-4), 163.4 (0, C-2), 162.2 (0, C-7)+, 162.2 (0, C-5) +, 160.8 (0, C-4\u2032) +, 156.6 (0, C-9), 127.8(1 and 1, overlapped C-2\u2032 and C-6\u2032), 120.5 (0, C-1\u2032), 115.9 (1 and 1, overlapped C-3\u2032 andC-5\u2032), 109.8 (0, C-6), 104.6 (0, C-10), 102.8 (1, C-3), 89.1 (1, C-8), 82.1 (1, C-5\u201d), 79.9 (1, C-3\u201d)73.7 (1, C-2\u201d), 71.4 (1, C-1\u201d) #, 70.5 (1, C-4\u201d) #, 62.4 (2, C-6\u201d), 55.1 (3, OCH3). 13C-NMR(75 MHz, CD3OD) \u03b4C 183.9 (0, C-4), 166.6 (0, C-2), 166.6 (0, C-7), 164.0 (0, C-4\u2032) +, 163.9(0, C-5) +, 159.1 (0, C-9), 129.6 (1 and 1, overlapped C-2\u2032 and C-6\u2032), 122.4 (0, C-1\u2032), 117.4(1 and 1, overlapped C-3\u2032 and C-5\u2032), 110.5 (0, C-6), 106.4 (0, C-10), 103.9 (1, C-3), 91.3 (1,C-8), 82.6 (1, C-5\u201d), 80.5 (1, C-3\u201d), 74.5 and 74.8 (1, C-2\u201d) *, 72.2 and 72.4 (1, C-1\u201d) *, 71.6(1, C-4\u201d), 63.4 (3, C-6\u201d), 56.7 and 57.0 (3, OCH3) *. #,+ Assignments are interchangeable; *signal duplication indicating the presence of two rotamers, in the ratio of about 52:48, dueto restricted rotation around the C(sp3)-C(sp2) glucosyl-flavone linkage (C-6-C-1\u201d) [68,83].The numbers in parentheses are the protons attached to the corresponding carbon andwere determined by DEPT experiments.2\u201d-O-\u03b1-L-Rhamnosyl swertisin [4\u2032,5-dihydroxy-7-methoxyflavone-6-C-(\u03b1-L-rhamnopy-ranosyl-1\u21922-\u03b2-D-glucopyranoside)] (112): Yellow powder; TLC (RP-18, MeOH/H2O, 7:3):Rf = 0.53. UV \u03bbmax (MeOH): 270, 332 nm; the molecular formula C28H32O14 was inferredMolecules 2021, 26, 264 15 of 21from the [M + Na]+ ion peak at m/z 615.50 in the ESI-MS (positive ion mode) spectrumand the [M \u2212 H]\u2212 ion peak at m/z 591.42 in the ESI-MS (negative ion mode) spectrum;1H-NMR (300 MHz, CD3OD) \u03b4 7.86 (2H, d, J = 8.8 Hz, H-2\u2032, 6\u2032), 6.90 (2H, d, J = 8.5 Hz,H-3\u2032, 5\u2032), 6.72 (1H, s, H-8), 6.63 (1H, s, H-3), 5.21 and 5.08 (1H overall, d and d, J = 1.6 Hz,H-1\u2032\u2032\u2032) *, 4.91 and 4.86 (1H overall, d and d, J = 9.8 Hz, H-1\u201d) *, 4.52 and 4.46 (1H overall, ddand dd, J = 9.6 and 8.6 Hz, H-2\u201d) *, 3.92 and 3.89 (3H overall, s and s, 7-OCH3) *, 3.85-3.95(m, 2H, H-6\u201db and H-2\u2032\u2032\u2032), 3.60\u20133.75 (1H, m, H-6\u201da), 3.50 (1H, t, J = 8.8 Hz, H-3\u201d), 3,39 (1H,t, J = 9.0 Hz, H-3\u2032\u2032\u2032) *, 3.30-3.45 (3H, m, H-4\u201d, H-5\u201d, H-3\u2032\u2032\u2032), 3.08 (1H, t, J = 9.5 Hz, H-4\u2032\u2032\u2032),2.30\u20132.40 and 2.60\u20132.70 (1H overall, m and m, H-5\u2032\u2032\u2032) *, 0.69 and 0.62 (3H overall, d andd, J = 6.2 Hz, H3-6\u2032\u2032\u2032) *, 13C-NMR (75 MHz, CD3OD) \u03b4C 184.0 and 184.3 (0, C-4) *, 166.5and 166.7 (0, C-7) *, 165.4 (0, C-2), 162.9 and 163.0 (0, C-4\u2032) *, 161.2 and 161.7 (0, C-5) *,159.1 and 159.3 (0, C-9) *, 129.5 and 129.6 (1 and 1, overlapped C-2\u2032 and C-6\u2032) *, 123.0 and122.9 (0, C-1\u2032) *, 117.1 (1 and 1, overlapped C-3\u2032 and C-5\u2032), 110.7 and 111.0 (0, C-6), 105.9and 106.4 (0, C-10), 104.1 and 104.3 (1, C-3) *, 102.2 and 103.0 (1, C-1\u2032\u2032\u2032) *, 91.6 and 92.2(1, C-8) *, 82.4 and 82.5 (1, C-5\u201d) *, 81.3 and 81.7 (1, C-3\u201d), 76.8 and 78.9 (1, C-2\u201d) *, 73.5and 73.7 (1, C-4\u2032\u2032\u2032) *, 72.8 and 73.2 (1, C-1\u201d) *, 72.4 (1, C-2\u2032\u2032\u2032) +, 72.0, 72.1 and 72.2 (1 and1, C-4\u201d and C-3\u2032\u2032\u2032) *,+, 69.9 (1, C-5\u2032\u2032\u2032), 63.3 (2, C-6\u201d), 56.7 and 57.1 (3, 7-OCH3) *, 18.0 and18.2 (3, C-6\u2032\u2032\u2032).* Signal duplication due to the presence of two rotamers [68,83] in the ratioof about 62:38; + assignments are interchangeable. The numbers in parentheses are theprotons attached to the corresponding carbon and were determined by DEPT experiments.Proton and carbon signals were assigned on the basis of COSY, HSQC, HMBC (112A), andNOESY correlations. Acid hydrolysis (3% aqueous H2SO4) of 112 yielded swertisin (111)as the aglycone, and L-rhamnose, compared with an authentic sample by TLC and opticalrotation.Trans-\u03b5-viniferin (113): Pale yellow powder; mp: 148\u2013150 \u25e6C; UV \u03bbmax (MeOH): 220,305 and 320 nm; IR (nujol) 3350, 1610, 1575, 1505, 1330, 1256, 1160 cm\u22121; the molecularformula C28H22O6 was inferred from the [M + H]+, [M + Na]+ and [2M + Na]+ ion peaksat m/z 455.20, 477.21 and 930.94, respectively, in the ESI-MS (positive ion mode) spectrumand the [M \u2212 H]\u2212 ion peak at m/z 453.31 in the ESI-MS (negative ion mode) spectrum;1H-NMR (300 MHz, CD3OD) \u03b4 7.11 (2H, d, J = 8.5 Hz, H-2\u2032 and H-6\u2032), 7.01 (2H, d, J = 8.5Hz, H-2 and H-6), 6.79 (1H, d, J = 16.4 Hz, H-7\u2032), 6.74 (2H, d, J = 8.5 Hz, H-3\u2032 and H-5\u2032),6.62 (2H, d, J = 8.5 Hz, H-3 and H-5), 6.60 (1H, d, J = 1.8 Hz, H-14\u2032), 6.54 (1H, d, J = 16.3Hz, H-8\u2032), 6.22 (1H, d, J = 1.8 Hz, H-12\u2032), 6.16-6.14 (3H, m, H-10, H-12 and H-14), 5.33 (1H,d, J = 6.6 Hz, H-7), 4.32 (1H, d, J = 6.6 Hz, H-8); 13C-NMR (75 MHz, CD3OD) \u03b4C 162.7 (0,C-11\u2032), 160.1 (0 and 0, overlapped C-11 and C-13), 159.8 (0, C-13\u2032) +, 158.5 (0, C-4\u2032) +, 158.4(0, C-4) +, 147.4 (0, C-9), 136.9 (0, C-9\u2032), 133.9 (0, C-1), 130.4 (0, C-1\u2032), 130.3 (1, C-7\u2032), 128.8 (1and 1, overlapped C-2\u2032 and C-6\u2032), 128.2 (1 and 1, overlapped C-2 and C-6), 123.7 (1, C-8\u2032),120.1 (0, C-10\u2032), 116.4 (1 and 1, overlapped C-3 and C-5), 116.3 (1 and 1, overlapped C-3\u2032and C-5\u2032), 107.4 (1 and 1, overlapped C-10 and C-14), 104.4 (1, C-14\u2032), 102.3 (1, C-12), 96.9(1, C-12\u2032), 94.8 (1, C-7), and 58.3 (1, C-8); + assignments are interchangeable. The numbersin parentheses are the protons attached to the corresponding carbon and were determinedby DEPT experiments. The NMR spectra matched those reported in literature [84,85];however, some assignments were corrected.Resveratrol 3,4\u2032-O-di-\u03b2-D-glucopyranoside (114): Pale yellow powder; the molecularformula C26H32O13 was inferred from the [M + Na]+ ion peak at m/z 575.28 in the ESI-MS(positive-ion mode) spectrum; 1H-NMR (300 MHz, CD3OD) \u03b4 7.44 (2H, d, J = 8.7 Hz, H-2\u2032and H-6\u2032), 7.05 (2H, d, J = 8.7 Hz, H-3\u2032 and H-5\u2032), 7.03 (1H, d, J = 16.4 Hz, H-8), 6.90 (1H,d, J = 16.4 Hz, H-7), 6.78 (1H, br s, H-2), 6.57 (1H, br s, H-6), 6.44 (1H, t, J = 2.1 Hz, H-4),4.89 (1H, d, J = 8.0 Hz, H-1\u201d)+, 4.86 (1H, d, J = 8.0 Hz, H-1\u2032\u2032\u2032)+, 3.85-3.97 (2H, m, H-6\u201db andH-6\u2032\u2032\u2032b), 3.67 (2H, two overlapped dd, J = 12.0 and 5.1 Hz, H-6\u201da and H-6\u2032\u2032\u2032a), 3.35\u20133.50 (8H,m, H-2\u201d, H-2\u2032\u2032\u2032, H-3\u2032\u2019, H-3\u2032\u2032\u2032, H-4\u2032\u2019, H-4\u2032\u2032\u2032, H-5\u201d, H-5\u2032\u2032\u2032); +assignments are interchangeable;13C-NMR (75 MHz, CD3OD) \u03b4C 160.5 (0, C-3), 159.6 (0, C-5), 158.8 (0, C-4\u2032), 141.1 (0, C-1),133,1 (0, C-1\u2032), 129.4 (1, C-8), 128.7 (1 and 1, overlapped C-2\u2032 and C-6\u2032), 128.2 (1, C-7), 117.9 (1and 1, overlapped C-3\u2032 and C-5\u2032), 108.5 (1, C-6), 107.1 (1, C-2), 104.4 (1, C-4), 102.4 and 102.2Molecules 2021, 26, 264 16 of 21(1 each, C-1\u201d and C-1\u2032\u2032\u2032), 78.4, 78.3, 78.2, 78,1 (1 each, C-5\u201d, C-5\u2032\u2032\u2032, C-3\u201d and C-3\u2032\u2032\u2032), 74.9 and74.9 (1 each, C-2\u201d and C-2\u2032\u2032\u2032), 71.5 and 71.4 (1 each, C-4\u201d and C-4\u2032\u2032\u2032), 62.6 and 62.5 (2 each,C-6\u201d and C-6\u2032\u2032\u2032). The numbers in parentheses are the protons attached to the correspondingcarbon and were determined by DEPT experiments. Signal assignments to protons andcarbons were established on the basis of COSY, HSQC, HMBC, and NOESY correlations.The data are in accordance with those reported in literature [86]. Acid hydrolysis (3%aqueous H2SO4) provided D-glucose, identical by TLC and comparison of the opticalrotation with an authentic sample.Isotectorigenin (pseudotectorigenin or psi-tectorigenin) (4\u2032,5,7-trihydroxy-8-methoxyi-soflavone) (115): Pale yellow powder, TLC (RP-18, MeOH/H2O, 8:2): Rf = 0.52. UV \u03bbmax(MeOH): 269, 336 (sh) nm; the molecular formula C16H12O6 was inferred from the [2M+ Na]+ ion peak at m/z 622.97 and the [M+Na]+ ion peak at m/z 323.12 in the ESI-MS(positive ion mode) spectrum, and the [M \u2212 H]\u2212 ion peak at m/z 299.17 in the ESI-MS(negative ion mode) spectrum. 1H-NMR (300 MHz, CD3OD) \u03b4 7.81 (1H, s, H-2), 7.30 (2H, d,J = 8.4 Hz, H-2\u2032, 6\u2032), 6.79 (2H, d, J = 8.4 Hz, H-3\u2032, 5\u2032), 6.09 (1H, s, H-6), 3.77 (3H, s, 8-OCH3).13C-NMR (75 MHz, CD3OD) \u03b4C 181.0 (0, C-4), 159.7 (0, C-7), 158.8 (0, C-4\u2032), 156.7 (0, C-9),153.7 (0, C-5), 153.3 (1, C-2), 137.2 (0, C-8), 131.5 (1 and 1, C-2\u2032 and C-6\u2032), 124.1 (0, C-3), 123.4(0, C-1\u2032), 116.3 (1 and 1, C-3\u2032 and C-5\u2032), 102.3 (0, C-10), 98.2 (1, C-6), 60.6 (3, 8-OCH3). Thenumbers in parentheses are the protons attached to the corresponding carbon and weredetermined by DEPT experiments. Proton and carbon signals were assigned on the basisof HSQC, HMBC, and NOESY correlations. The data are in accordance with those reportedin literature [87].3.5. Free Radical Scavenging ActivityBriefly, a 0.3 mM solution of DPPH in MeOH was prepared. To 1 mL of this solution,3 mL of sample or extract solution in 10% aqueous MeOH at different concentrations (10,25, 50, 100, 150, 200, 250, 350 \u00b5g/mL) was added. Subsequently, the mixture was shakenvigorously and incubated for 30 min at 22 \u25e6C in the dark until a stable absorbance value(A) at 517 nm was obtained, that was measured using a UV-Visible spectrophotometer(Lambda 25 UV/Vis spectrometer N.3903, Perkin Elmer instruments, Waltham, MA, USA).A lower absorbance of the reaction mixture indicated higher free radical scavenging (FRS)activity. The DPPH solution (1 mL), plus 10% MeOH (3 mL), was used as the control. TheFRS% was calculated using the formula: [1 \u2212 (Asample/Acontrol)] \u00d7 100. The curve of the% scavenging activity against the concentration was plotted for each sample using theMS Excel-based program to calculate the EC50 value, i.e., the concentration (\u00b5g/mL or\u00b5M/L) of the sample required to scavenge 50% of the initial DPPH concentration. Eachanalysis was carried out in triplicate and the mean \u00b1 SD (n = 3) was calculated. Ascorbicacid (Sigma-Aldrich) was used as a standard antiradical agent. The lower the EC50 value,the higher the sample antiradical activity. The antiradical activity was also expressed asascorbic acid equivalents (AAEs) (Table 2), i.e., \u00b5g ascorbic acid equivalents/\u00b5g sample.These values were calculated using the formula: EC50 ascorbic acid (\u00b5g/mL)/EC50 sample(\u00b5g/mL) [77].3.6. Total Antioxidant Capacity (TAOC\u2014Ammonium Phosphomolybdate Assay)Briefly, samples of dry extracts or standard ascorbic acid, dissolved in MeOH/distilledH2O (50:50), were combined with 3.0 mL of reagent solution (0.6 M sulfuric acid, 28 mMsodium phosphate and 4 mM ammonium molybdate) to achieve a series of eight finalconcentrations in the range of 12\u2013450 \u00b5g/mL. The tubes were capped and incubated in aboiling water bath at 95 \u25e6C for 90 min. The samples were cooled to 22 \u25e6C and absorbancewas measured at 695 nm against the blank using the cited UV-Visible spectrophotometer.From each series of measures, a sigmoidal curve was obtained by data interpolation andthe EC50 value of each sample was calculated as the concentration corresponding to 50%activity. The blank contained 3.0 mL of the reagent solution and 0.3 mL of MeOH/distilledH2O (50:50), and it was incubated under the same conditions as the samples. Each analysisMolecules 2021, 26, 264 17 of 21was carried out in triplicate and the mean \u00b1 SD (n = 3) was calculated. The TAOC valueswere expressed as \u00b5g ascorbic acid equivalents/\u00b5g extract (Table 2). They were calculatedusing the formula: EC50 (\u00b5g/mL) ascorbic acid)/EC50 (\u00b5g/mL) extract. The EC50 ofascorbic acid used in TAOC calculation was 26.12 \u00b1 0.56 \u00b5g/mL.3.7. Acid Hydrolysis of Compounds 112 and 114Compounds 112 and 114 (2.0 mg each) were separately dissolved in 3% aqueousH2SO4 in a sealed vial and heated at 90 \u25e6C for 45 min. After cooling to room temperatureand extraction with CHCl3, the aqueous layer was repeatedly evaporated to drynesswith the aid of MeCN. The residues were identified as L-(+)-rhamnose and D-(+)-glucose,respectively, by TLC and optical rotation upon comparison with authentic samples.4. ConclusionsA dozen Iris species are used in the traditional medicine of Kurdistan. In the first partof this paper, we have reported the structures of the main constituents, traditional uses andbiological activities found in the literature for the few species growing in Kurdistan thathave been investigated so far. The most characteristic secondary metabolites are various ter-penoids, among which iridal derivatives are the most typical ones, and phenolic derivatives,among which isoflavones predominate. Most of these Iris metabolites exhibited variousbioactivities. Based on these data, we then investigated, for the first time, the contents ofthe methanolic extracts of I. postii aerial parts and rhizomes. L-tryptophan, androsin (66),apigenin 6-C-glucoside (isovitexin) (109), swertisin (111), and 2\u201d-O-rhamnosyl swertisin(112) were isolated from the aerial parts, whereas chromatographic separation of the extractfrom rhizomes afforded trans-\u03b5-viniferin (113), trans-resveratrol 3,4\u2032-O-diglucoside (114),and isotectorigenin (115). To the best of our knowledge, this is the first finding of com-pounds 112\u2013115 in the genus Iris. Isolated compounds showed a wide range of bioactivities,in addition to the excellent radical-scavenging properties exhibited in this investigationby 2\u201d-O-\u03b1-L-rhamnosyl- swertisin (112), \u03b5-viniferin (113), and resveratrol 3,4\u2032-O-di-\u03b2-D-glucopyranoside (114). Thus, isovitexin (109) has been reported to be an anti-inflammatory,antihyperglycemic, sedative agent with insulin secretagogue properties and to displayantioxidant, anti-inflammatory, neuroprotective, anti-diabetic, antitumor effects [88,89];swertisin (111) exhibited antioxidant, anti-inflammatory, antihyperglycemic activities withinsulin secretagogue and adenosine A1 receptor antagonist properties [90]; swertisin(111) and 2\u201d-O-rhamnosylswertisin (112) exhibited strong \u03b1-glucosidase inhibitory activityin vitro [91] and effective mechanical antinociceptive properties [81]; \u03b5-viniferin exhibitedrelatively strong inhibition of \u03b1-glucosidase in vitro [92] and inhibited both human LDLand HDL oxidation in vitro [85]; resveratrol diglucoside 114 decreased ethanol-inducedoxidative DNA damage in mouse brain cells, possibly via inhibition of oxidative stress [93],and displayed highly selective antiproliferative activity against tumor cells [94].In conclusion, the few Iris species growing in Kurdistan that have been investigatedso far demonstrated to be novel viable sources of various bioactive compounds. Moreover,the remarkable antioxidant and radical scavenging activities of the methanol extracts ofaerial parts and rhizomes of I. postii, as well as the anti-inflammatory properties reportedfor different isolated compounds, validate the traditional medicinal use of this plant inKurdistan. Further studies aimed to evaluate the in vivo potential of Iris extracts in variousmodels and to isolate and identify the antioxidant principles occurring in the most polarfractions of the methanolic extract of I. postii aerial parts shall be carried out in due time.Supplementary Materials: NMR and MS spectra of isolated compounds are available online,Figure S1: 1H-NMR spectrum (300 MHz, CD3OD) of androsin, Figure S2: 13C-NMR spectrum(75 MHz, CD3OD) of androsin, Figure S3: ESI-MS (positive ion mode) spectrum of androsin,Figure S4: 1H-NMR spectrum (300 MHz, CD3OD) of isovitexin, Figure S5: 13C-NMR spectrum(75 MHz, CD3OD) of isovitexin, Figure S6: ESI-MS (positive ion mode) spectrum of isovitexin,Figure S7: ESI-MS (negative ion mode) spectrum of isovitexin, Figure S8: 1H-NMR spectrum(300 MHz, CD3OD) of swertisin, Figure S9: 13C-NMR spectrum (75 MHz, CD3OD) of swertisin,Molecules 2021, 26, 264 18 of 21Figure S10: 13C-NMR spectrum (75 MHz, C5D5N) of swertisin, Figure S11: ESI-MS (positive ionmode) spectrum of swertisin, Figure S12: ESI-MS (negative ion mode) spectrum of swertisin,Figure S13: 1H-NMR spectrum (300 MHz, CD3OD) of 2\u201d-O-\u03b1-L-rhamnosyl swertisin, Figure S14:COSY spectrum of 2\u201d-O-\u03b1-L-rhamnosyl swertisin, Figure S15: 13C-NMR spectrum (75 MHz, CD3OD)of 2\u201d-O-\u03b1-L-rhamnosyl swertisin, Figure S16: HSQC spectrum of 2\u201d-O-\u03b1-L-rhamnosyl swertisin,Figure S17: HMBC spectrum of 2\u201d-O-\u03b1-L-rhamnosyl swertisin, Figure S18: HMBC spectrum (en-largement 1) of 2\u201d-O-\u03b1-L-rhamnosyl swertisin, Figure S19: HMBC spectrum (enlargement 2) of2\u201d-O-\u03b1-L-rhamnosyl swertisin, Figure S20: NOESY spectrum of 2\u201d-O-\u03b1-L-rhamnosyl swertisin,Figure S21: ESI-MS spectra (positive and negative ion mode) of 2\u201d-O-\u03b1-L-rhamnosyl swertisin,Figure S22: 1H-NMR spectrum (300 MHz, CD3OD) of tryptophan, Figure S23: 13C-NMR spectrum(75 MHz, CD3OD) of tryptophan, Figure S24: ESI-MS (positive ion mode) spectrum of tryptophan,Figure S25: 1H-NMR spectrum (300 MHz, CD3OD) of isotectorigenin, Figure S26: 13C-NMR spec-trum (75 MHz, CD3OD) of isotectorigenin, Figure S27: ESI-MS (positive ion mode) spectrum ofisotectorigenin, Figure S28: ESI-MS (negative ion mode) spectrum of isotectorigenin, Figure S29:1H-NMR spectrum (300 MHz, CD3OD) of trans-\u03b5-viniferin, Figure S30: 13C-NMR spectrum (75 MHz,CD3OD) of trans-\u03b5-viniferin, Figure S31: ESI-MS (positive ion mode) spectrum of trans-\u03b5-viniferin,Figure S32: ESI-MS (negative ion mode) spectrum of trans-\u03b5-viniferin, Figure S33: 1H-NMR spectrum(300 MHz, CD3OD) of resveratrol-3,4\u2032-O-di-\u03b2-D-glucopyranoside, Figure S34: 13C-NMR spectrum(75 MHz, CD3OD) of resveratrol-3,4\u2032-O-di-\u03b2-D-glucopyranoside, Figure S35: HSQC spectrum ofresveratrol 3,4\u2032-O-di-\u03b2-D-glucopyranoside, Figure S36: HMBC spectrum of resveratrol-3,4\u2032-O-di-\u03b2-D-glucopyranoside, Figure S37: NOESY spectrum of resveratrol 3,4\u2032-O-di-\u03b2-D-glucopyranoside,Figure S38: ESY-MS spectrum (positive ion mode) of resveratrol-3,4\u2032-O-di-\u03b2-D-glucopyranoside.Author Contributions: Conceptualization and supervision, G.V. and F.H.S.H.; data curation, Z.M.T.and H.I.M.A.; investigation, H.I.M.A., G.G., S.K.N. and M.F.I.; writing original draft, G.V.; writing\u2014review and editing, G.V., F.H.S.H. and G.G. All authors have read and agreed to the published versionof the manuscript.Funding: This research received no external funding.Data Availability Statement: Raw data are available in supplementary material.Acknowledgments: The authors are indebted to Abdul Hussain Al Khayyat and Abdullah S. A., theUniversity of Salahaddin-Erbil, Iraq, for the plant identification. Raffaella Gaggeri, Dipartimento diScienze del Farmaco, and Daniela Buonocore, Dipartimento di Biologia e Biotecnologie, University ofPavia, are thanked for technical assistance in the DPPH and TAOC assays. The Universidad T\u00e9cnicaParticular de Loja (UTPL) is acknowledged for supporting open access publication.Conflicts of Interest: The authors declare no conflict of interest.Sample Availability: Samples of the compounds are not available from the authors.References1. Nedhal, A.; Luay, Y. A survey of plants used in Iraqi traditional medicine. Jordan J. Pharm. Sci. 2010, 3, 100\u2013107.2. Solecki, R.S. Shanidar IV, a Neanderthal Flower Burial in Northern Iraq. Science 1975, 190, 880\u2013881. [CrossRef]3. Nahida, A. The most medicinal plants used in Iraq: Traditional knowledge. Adv. Environ. Biol. 2011, 5, 401\u2013406.4. Mati, E.; De Boer, H. Ethnobotany and trade of medicinal plants in the Qaysari Market, Kurdish Autonomous Region, Iraq.J. Ethnopharmacol. 2011, 133, 490\u2013510. [CrossRef] [PubMed]5. Amin, H.I.M.; Ibrahim, M.F.; Hussain, F.H.S.; Sardar, A.S.; Vidari, G. Phytochemistry and ethnopharmacology of some me-dicinalplants used in the Kurdistan region of Iraq. Nat. Prod. Commun. 2016, 11, 291\u2013296. [PubMed]6. WCSP. World Checklist of Selected Plant Families. Available online: Wcsp.science.kew.org (accessed on 2 June 2014).7. Iris. Pacific Bulb Society. Available online: https://www.pacificbulbsociety.org (accessed on 3 March 2012).8. Ka\u0161\u0161\u00e1k, P. Secondary metabolites of the chosen genus Iris species. Acta Univ. Agric. Silvic. Mendel. Brun. 2012, 60, 269\u2013280.[CrossRef]9. Kukula-Koch, W.; Sieniawska, E.; Widelski, J.; Urjin, O.; G\u0142owniak, P.; Skalicka-Woz\u0301niak, K. Major secondary metabolites of Irisspp. Phytochem. Rev. 2015, 14, 51\u201380. [CrossRef]10. Brenna, E.; Fuganti, C.; Serra, S. From commercial racemic fragrances to odour active enantiopure compounds: The ten isomersof irone. C. R. Chim. 2003, 6, 529\u2013546. [CrossRef]11. Townsend, C.; Guest, E. (Eds.) Flora of Iraq, Vol. 8: Monocotyledons; Baghdad-Ministry of Agriculture & Agrarian Reform: Baghdad,Iraq, 1985.Molecules 2021, 26, 264 19 of 2112. Amin, H.I.M.; Amin, A.A.; Tosi, S.; Mellerio, G.G.; Hussain, F.H.S.; Picco, A.M.; Vidari, G. Chemical composition and anti-fungalactivity of essential oils from flowers, leaves, rhizomes, and bulbs of the wild Iraqi Kurdish plant Iris persica. Nat. Prod. Commun.2017, 12, 441\u2013444.13. Amin, H.I.M.; Hussain, F.H.S.; Maggiolini, M.; Vidari, G. Bioactive constituents from the traditional Kurdish plant Iris persica. Nat.Prod. Commun. 2018, 13, 1127\u20131128. [CrossRef]14. Rahman, A.-U.; Nasim, S.; Baig, I.; Jalil, S.; Orhan, I.; Sener, B.; Choudary, M.I. Antiinflammatory isoflavonoids from rhizomes ofIris germanica. J. Ethnopharmacol. 2003, 86, 177\u2013180. [CrossRef]15. Sch\u00fctz, C.; Quitschau, M.; Hamburger, M.; Potterat, O. Profiling of isoflavonoids in Iris germanica rhizome extracts by microprobeNMR and HPLC\u2013PDA\u2013MS analysis. Fitoterapia 2011, 82, 1021\u20131026. [CrossRef] [PubMed]16. Shojaii, A.; Haghjoo, E.; Parvizi, M.M. Efficacy of topical herbal remedies for insomnia in Iranian traditional medicine. Pharmacogn.Res. 2019, 11, 188. [CrossRef]17. Rahman, A.-U.; Nasim, S.; Baig, I.; Orhan, I.E.; S\u0327ener, B.; Ayanoglu, F.; Choudhary, M.I. Isoflavonoid Glycosides from theRhizomes of Iris germanica. Helvetica Chim. Acta 2003, 86, 3354\u20133362. [CrossRef]18. Abu-Dahab, R. Antiproliferative activity of selected medicinal plants of Jordan against a breast adenocarcinoma cell line (MCF7).Sci. Pharm. 2007, 75, 121\u2013136. [CrossRef]19. Halpert, M.; Abu-Abied, M.; Avisar, O.; Moskovitz, Y.; Altshuler, O.; Cohen, A.; Weissberg, M.; Riov, J.; Gottlieb, H.E.; Perl,A.; et al. Rac-dependent doubling of HeLa cell area and impairment of cell migration and cell cycle by compounds from Irisgermanica. Protoplasma 2011, 248, 785\u2013797. [CrossRef]20. Nadarog\u0306lu, H.; Demir, Y.; Demir, N. Antioxidant and radical scavenging properties of Iris germanica. Pharm. Chem. J. 2007, 41,409\u2013415. [CrossRef]21. Ullah, F.; Ayaz, M.; Sadiq, A.; Hussain, A.; Ahmad, S.; Imran, M.; Zeb, A. Phenolic, flavonoid contents, anticholinesterase andantioxidant evaluation of Iris germanica var; florentina. Nat. Prod. Res. 2015, 30, 1440\u20131444. [CrossRef]22. Basgedik, B.; Ugur, A.; Sarac, N.; Burcu, B.; Aysel, U.; Nurdan, S. Antimicrobial, antioxidant, antimutagenic activities, andphenolic compounds of Iris germanica. Ind. Crop. Prod. 2014, 61, 526\u2013530. [CrossRef]23. Asghar, S.F.; Aziz, S.; Habib-Ur-Rehman; Ahmed, I.; Hussain, H.; Rahman, A.-U.; Choudhary, M.I. Secondary metabolites isolatedfrom Iris germanica. Rec. Nat. Prod. 2009, 3, 139\u2013152.24. Ibrahim, S.R.M.; Mohamed, G.A.A.; Al Musayeib, N.M. New Constituents from the Rhizomes of Egyptian Iris germanica L.Molecules 2012, 17, 2587\u20132598. [CrossRef] [PubMed]25. Orhan, I.E.; Nasim, S.; Tener, B.; Ayanoglu, F.; \u00d6zg\u00fcven, M.; Choudhary, M.I.; Rahman, A.-U. Two isoflavones and bioactivityspectrum of the crude extracts of Iris germanica rhizomes. Phytotherapy Res. 2003, 17, 575\u2013577. [CrossRef] [PubMed]26. Uzair, A.; Bakht, J.; Iqbal, A.; Naveed, K.; Ali, N. In vitro antimicrobial activities of different solvent extracted samples from Irisgermanica. Pak. J. Pharm. Sci. 2016, 29, 145\u2013150. [PubMed]27. Sala, E.; Guasch, L.; Iwaszkiewicz, J.; Mulero, M.; Salvad\u00f3, M.J.; Blad\u00e9, C.; Ceballos, M.; Valls, C.; Zoete, V.; Grosdidier, A.; et al.Identification of human IKK-2 inhibitors of natural origin (Part II): In Silico prediction of IKK-2 inhibitors in natural extracts withknown anti-inflammatory activity. Eur. J. Med. Chem. 2011, 46, 6098\u20136103. [CrossRef]28. Hoang, L.; Bene\u0161, F.; Fenclova, M.; Kronusova, O.; \u0160varcov\u00e1, V.; R\u030cehor\u030cov\u00e1, K.; \u0160vecov\u00e1, E.B.; Vos\u00e1tka, M.; Hajslova, J.; Ka\u0161t\u00e1nek, P.;et al. Phytochemical Composition and In Vitro Biological Activity of Iris spp. (Iridaceae): A New Source of Bioactive Constituentsfor the Inhibition of Oral Bacterial Biofilms. Antibiot. 2020, 9, 403. [CrossRef]29. Muto, Y.; Ichikawa, H.; Kitagawa, O.; Kumagai, K.; Watanabe, M.; Ogawa, E.; Seiki, M.; Shirataki, Y.; Yokoe, I.; Komatsu, M.; et al.Studies on Antiulcer Agents. I. The Effects of Various Methanol and Aqueous Extracts of Crude Drugs on Antiulcer Activity.Yakugaku Zasshi 1994, 114, 980\u2013994. [CrossRef]30. Choudhary, M.I.; Naheed, S.; Jalil, S.; Alam, J.M.; Rahman, A.-U. Effects of ethanolic extract of Iris germanica on lipid profile ofrats fed on a high-fat diet. J. Ethnopharmacol. 2005, 98, 217\u2013220. [CrossRef]31. Singab, A.N.B.; Ahmed, A.H.; Sinkkonen, J.; Ovcharenko, V.; Pihlaja, K. Molluscicidal Activity and New Flavonoids fromEgyptian Iris germanica L. (var. alba). Z. Naturforsch. C 2006, 61, 57\u201363. [CrossRef]32. Borhani, M.; Sharifzadeh, M.; Farzaei, M.H.; Narimani, Z.; Sabbaghziarani, F.; Gholami, M.; Rahimi, R. Protective effect of Irisgermanica L. in \u03b2-amyloid-induced animal model of alzheimer\u2019s disease. Afr. J. Tradit. Complement. Altern. Med. 2017, 14, 140\u2013148.[CrossRef]33. Rahman, A.-U.; Nasim, S.; Baig, I.; Jahan, I.A.; Sener, B.; Orhan, I.; Choudhary, M.I. Isoflavonoid glycosides from the rhizomes ofIris germanica. Chem. Pharm. Bull. 2002, 50, 1100\u20131102. [CrossRef]34. Xie, G.-Y.; Qin, X.-Y.; Liu, R.; Wang, Q.; Lin, B.-B.; Wang, G.-K.; Xu, G.-K.; Wen, R.; Qin, M. New isoflavones with cytotoxic activityfrom the rhizomes of Iris germanica L. Nat. Prod. Res. 2013, 27, 2173\u20132177. [CrossRef] [PubMed]35. Xie, G.-Y.; Chen, Y.-J.; Wen, R.; Xu, J.-Y.; Wu, S.-S.; Qin, M.-J. Chemical constituents from rhizomes of Iris germanica. China J. Chin.Mater. Medica 2014, 39, 846\u2013850.36. Kawase, A.; Ohta, N.; Yagishita, K. On the Chemical Structure of a New Isoflavone Glucoside, Homotectoridin, Isolated Togetherwith Tectoridin from the Rhizomes of Iris germanica Linnaeus. Agric. Biol. Chem. 1973, 37, 145\u2013150. [CrossRef]37. Ali, A.; Elemary, N.; Elmoghazi, M.; Darwish, F.; Frahm, A. Three isoflavonoids from Iris germanica. Phytochemistry 1983, 22,2061\u20132063. [CrossRef]Molecules 2021, 26, 264 20 of 2138. Ibrahim, S.R.M.; Mohamed, G.A.; Zayed, M.F.; Ross, S.A. 8-Hydroxyirilone 5-methyl ether and 8-hydroxyirilone, new antioxidantand \u03b1-amylase inhibitors isoflavonoids from Iris germanica rhizomes. Bioorganic Chem. 2017, 70, 192\u2013198. [CrossRef]39. Akashi, T.; Ishizaki, M.; Aoki, T.; Ayabe, S.-I. Isoflavonoid production by adventitious root cultures of Iris germanica (Iridaceae).Plant. Biotechnol. 2005, 22, 207\u2013215. [CrossRef]40. Ibrahim, S.R.M.; Al-Ahdal, A.; Khedr, A.; Mohamed, G.A.A. Antioxidant \u03b1-amylase inhibitors flavonoids from Iris germanicarhizomes. Rev. Bras. Farm. 2017, 27, 170\u2013174. [CrossRef]41. Mohamed, G.A.; Ibrahim, S.R.; Ross, S.A. New ceramides and isoflavone from the Egyptian Iris germanica L. rhizomes. Phytochem.Lett. 2013, 6, 340\u2013344. [CrossRef]42. Wollenweber, E.; Stevens, J.F.; Klimo, K.; Knauft, J.; Frank, N.; Gerh\u00e4user, C. Cancer Chemopreventive in vitro Activities ofIsoflavones Isolated from Iris germanica. Planta Medica 2003, 69, 15\u201320. [CrossRef]43. Nazir, N.; Koul, S.; Qurishi, M.A.; Taneja, S.C.; Ahmad, S.F.; Khan, B.; Bani, S.; Qazi, G.N. Immunomodulatory activityof isoflavones isolated from Iris germanica (Iridaceae) on T-lymphocytes and cytokines. Phytotherapy Res. 2009, 23, 428\u2013433.[CrossRef]44. Roger, B.; Jeannot, V.; Fernandez, X.; Cerantola, S.; Chahboun, J. Characterisation and Quantification of Flavonoids in Irisgermanica L. and Iris pallida Lam. Resinoids from Morocco. Phytochem. Anal. 2012, 23, 450\u2013455. [CrossRef]45. Pailer, M.; Franke, F. Constituents of Iris germanica. Monatsh. Chem. 1973, 104, 1394\u20131408. [CrossRef]46. Asghar, S.F.; Rehman, H.-U.; Rahman, A.-U.; Choudhary, M.I. Phytochemical investigations on Iris germanica. Nat. Prod. Res.2010, 24, 131\u2013139. [CrossRef] [PubMed]47. Alam, A.; Verma, M.; Naik, K.K.; Choudhary, D.; Kumar, S. Anti-osteoporotic activity of isoflavones from Iris germanica targetingNF-kappaB. Int. J. Pharm. Investig. 2019, 8, 122\u2013129. [CrossRef]48. Xin, R.-h.; Zheng, J.-f.; Cheng, L.; Peng, W.-j.; Luo, Y.-j. Belamcanda chinensis (L.) DC: Ethnopharmacology, phytochemistry andpharmacology of an important traditional Chinese medicine. Afr. J. Tradit. Complement. Altern. Med. 2015, 12, 39\u201370.49. Wuttke, W.; Jarry, H.; Popp, M.; Christoffel, V.; Spengler, B. Use of Extracts and Preparation from Iris Plants and Tectorigenin asMedicaments. U.S. Patent 20040176310, 15 May 2002.50. Choudhary, D.; Alam, A. Pharmacology and phytochemistry of isoflavonoids from Iris species. J. Pharm. Clin. Res. 2017, 3, 555609.51. Kang, K.A.; Zhang, R.; Piao, M.J.; Ko, D.O.; Wang, Z.H.; Kim, B.J.; Park, J.W.; Kim, H.S.; Kime, D.H.; Hyun, J.W. Protective ef-fectof irisolidone, a metabolite of kakkalide, against hydrogen peroxide induced cell damage via antioxidant effect. Bioorg. Med.Chem. 2008, 16, 1133\u20131141. [CrossRef] [PubMed]52. Kawase, A.; Yagishita, K. On the structure of a new C-Glycosyl flavone, embinin, isolated from the petals of Iris germanicaLinnaeous. Agric. Biol. Chem. 1968, 32, 537\u2013538. [CrossRef]53. Hilsenbeck, R.A.; Mabry, T.J. C-glycosylflavones from Siphonoglossa sessilis. Phytochemistry 1983, 22, 2215\u20132217. [CrossRef]54. Harborne, J.B. Comparative Biochemistry of the Flavonoids; Academic Press: London, UK, 1967; p. 383. ISBN 01-232-4650-4.55. Xie, G.; Qin, X.; Chen, Y.; Wen, R.; Wu, S. Alkaloids from the Rhizomes of Iris germanica. Chem. Nat. Compd. 2017, 53, 196\u2013198.[CrossRef]56. Jaenicke, L.; Marner, F.-J. The irones and their origin. Pure Appl. Chem. 1990, 65, 1365\u20131368. [CrossRef]57. Benoit-Vical, F.; Imbert, C.; Bonfils, J.-P.; Sauvaire, Y. Antiplasmodial and antifungal activities of iridal, a plant triterpenoid.Phytochemistry 2003, 62, 747\u2013751. [CrossRef]58. Bonfils, J.-P.; Sauvaire, Y. Localization of iridals in Iris germanica rhizomes. Phytochemistry 1996, 41, 1281\u20131285. [CrossRef]59. Bonfils, J.-P.; Pinguet, F.; Culine, S.; Sauvaire, Y. Cytotoxicity of Iridals, Triterpenoids from Iris, on Human Tumor Cell LinesA2780 and K562. Planta Medica 2001, 67, 79\u201381. [CrossRef] [PubMed]60. Miyake, Y.; Ito, H.; Yoshida, T. Identification of iridals as piscicidal components of Iridaceous plants and their conformationsassociated with CD spectra. Can. J. Chem. 1997, 75, 734\u2013741. [CrossRef]61. Marner, F.J.; Krick, W.; Gellrich, B.; Jaenicke, L.; Winter, W. Irigermanal and iridogermanal: Two new triterpenoids from rhizomesof Iris germanica L. J. Org. Chem. 1982, 47, 2531\u20132536. [CrossRef]62. Ito, H.; Miyake, Y.; Yoshida, T. New piscicidal triterpenes from Iris germanica. Chem. Pharm. Bull. 1995, 43, 1260\u20131262. [CrossRef]63. Potterat, O.; Herzog, C.; Raith, M.; Ebrahimi, S.N.; Hamburger, M. Irigermanone, a Noriridal with Unprecedented MethylketoneFunction, from Iris germanica. Helvetica Chim. Acta 2014, 97, 32\u201338. [CrossRef]64. Orhan, I.; Sener, B.; Hashimoto, T.; Asakawa, Y.; Ozg\u00fcven, M.; Ayanog\u0306lu, F. Iristectorone K, a novel monocyclic triterpene esterfrom Iris germanica rhizomes growing in Turkey. Fitoterapia 2002, 73, 316\u2013319. [CrossRef]65. Muto, Y.; Ichikawa, H.; Seiki, M.; Shirataki, Y.; Yokoe, I.; Komatsu, M. Studies on Antiulcer Agents. II. Synthesis and AntiulcerActivity of Phenylpropanol Derivatives. Yakugaku Zasshi 1994, 114, 995\u20131004. [CrossRef]66. Maurer, B.; Hauser, A.; Froidevaux, J.-C. New Irone-Related Constituents from the essential oil of Iris germanica L. Helvetica Chim.Acta 1989, 72, 1400\u20131415. [CrossRef]67. Bonfils, J.-P.; Bonfils, C.; Larroque, C.; Surjus, A.; Gleize, D.; Sauvaire, Y. Lipid composition of microsomes of Iris germanicarhizomes. Phytochemistry 1995, 38, 585\u2013587. [CrossRef]68. Davoust, D.; Massias, M.; Molho, D. 13C-NMR investigation of flavonoid C-\u03b2-D-glucosides. Detection of a conformationalequilibrium. Magn. Reson. Chem. 1980, 13, 218\u2013219. [CrossRef]69. Cheng, G.; Bai, Y.; Zhao, Y.; Tao, J.; Liu, Y.; Tu, G.; Ma, L.; Liao, N.; Xu, X. Flavonoids from Ziziphus jujuba Mill var. spinosa.Tetrahedron 2000, 56, 8915\u20138920. [CrossRef]Molecules 2021, 26, 264 21 of 2170. Bjor\u00f8y, \u00d8.; Rayyan, S.; Fossen, T.; Kalberg, K.; Andersen, \u00d8.M. C-glycosyl anthocyanidins synthesized from C-glycosylflavones.Phytochemistry 2009, 70, 278\u2013287. [CrossRef]71. Quint\u00e3o, N.L.M.; Meyre-Silva, C.; Silva, G.F.; Antonialli, C.S.; Rocha, L.W.; Lucinda-Silva, R.M.; Malheiros, A.; Souza, M.M.; Filho,V.C.; Bresolin, T. Aleurites moluccana (L.) Willd. Leaves: Mechanical Antinociceptive Properties of a Standardized Dried Extractand Its Chemical Markers. Evid. Based Complement. Altern. Med. 2011, 2011, 1\u201310. [CrossRef] [PubMed]72. Frank, J.H.; Powder-George, Y.L.; Ramsewak, R.S.; Reynolds, W.F. Variable Temperature 1H-NMR Studies on Two C-Glycosylflavones. Molecules 2012, 17, 7914\u20137926. [CrossRef] [PubMed]73. Fan, J.-S.; Lee, I.-J.; Lin, Y.-L. Flavone glycosides from commercially available Lophatheri herba and their chromatographicfingerprinting and quantitation. J. Food Drug Anal. 2015, 23, 821\u2013827. [CrossRef] [PubMed]74. Shirane, S.; Ohya, S.; Matsuo, T.; Hirose, R.; Koga, D.; Ide, A.; Yagishita, K. C-Glycosyl compounds in the leaves of Gemmingiachinensis O. KUNTZE. Agric. Biol. Chem. 1982, 46, 2595\u20132597. [CrossRef]75. Ames, B.N. Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 1983, 221, 1256\u20131264.[CrossRef] [PubMed]76. Reuter, S.; Gupta, S.C.; Chaturvedi, M.M.; Aggarwal, B.B. Oxidative stress, inflammation, and cancer: How are they linked? FreeRadicals Biol. Med. 2010, 49, 1603\u20131616. [CrossRef] [PubMed]77. Odunola, O.; Olugbami, J.O.; Gbadegesin, M.A. In vitro free radical scavenging and antioxidant properties of ethanol extract ofTerminalia glaucescens. Pharmacogn. Res. 2015, 7, 49\u201356. [CrossRef]78. Sun, L.; Zhang, J.; Lu, X.; Zhang, L.; Zhang, Y. Evaluation to the antioxidant activity of total flavonoids extract from persimmon(Diospyros kaki L.) leaves. Food Chem. Toxicol. 2011, 9, 2689\u20132696. [CrossRef]79. Umamaheswari, M.; Chatterjee, T.K. In vitro antioxidant activities of the fractions of Coccinia grandis L. leaf extract. Afr. J. Tradit.Complement. Altern. Med. 2008, 5, 61\u201373. [CrossRef]80. Gilardoni, G.; Chiriboga, X.; Finzi, P.V.; Vidari, G. New 3,4-Secocycloartane and 3,4-Secodammarane Triterpenes from theEcuadorian Plant Coussarea macrophylla. Chem. Biodivers. 2015, 12, 946\u2013954. [CrossRef] [PubMed]81. De Rosa, S.; De Giulio, A.; Tommonaro, G. Aliphatic and aromatic glycosides from the cell cultures of Lycopersicon esculentum.Phytochemistry 1996, 42, 1031\u20131034. [CrossRef]82. Ers\u00f6z, T.; Harput, \u00dc.S\u0327.; Saragog\u0306lu, I\u0307.; \u00c7alis\u0327, I.; Ogihara, Y. Phenolic compounds from Scutellaria pontica. Turk. J. Chem. 2002, 26,581\u2013588.83. Zhou, G.; Yan, R.; Wang, X.; Li, S.; Lin, J.; Liu, J.; Zhao, Z. The overlooked rotational isomerism of C-glycosyl flavonoids.Phytochem. Rev. 2019, 18, 443\u2013461. [CrossRef]84. Liu, W.-B.; Hu, L.; Hu, Q.; Chen, N.-N.; Yang, Q.-S.; Wang, F.-F. New Resveratrol Oligomer Derivatives from the Roots of Rheumihasaense. Molecules 2013, 18, 7093\u20137102. [CrossRef] [PubMed]85. Ngoc, T.M.; Hung, T.M.; Thuong, P.T.; Na, M.; Kim, H.; Ha, D.T.; Min, B.-S.; Minh, P.T.H.; Bae, K. Inhibition of human lowdensity lipoprotein and high density lipoprotein oxidation by oligostilbenes from rhubarb. Biol. Pharm. Bull. 2008, 31, 1809\u20131812.[CrossRef] [PubMed]86. Kanchanapoom, T.; Suga, K.; Kasai, R.; Yamasaki, K.; Kamel, M.S.; Mohamed, M.H. Stilbene and 2-arylbenzofuran glucosidesfrom the rhizomes of Schoenocaulon officinale. Chem. Pharm. Bull. 2002, 50, 863\u2013865. [CrossRef] [PubMed]87. Bai, X.; Qu, J.-L.; Liu, J.; Sun, J.-H.; Yuan, D. Isolation and identification of urinary metabolites of tectoridin in rats. J. Asian Nat.Prod. Res. 2011, 13, 604\u2013610. [CrossRef]88. He, M.; Min, J.-W.; Kong, W.-L.; He, X.-H.; Li, J.-X.; Peng, B.-W. A review on the pharmacological effects of vitexin and iso-vitexin.Fitoterapia 2016, 115, 74\u201385. [CrossRef]89. Ganesan, K.; Xu, B. Molecular targets of vitexin and isovitexin in cancer therapy: A critical review. Ann. N. Y. Acad. Sci. 2017,1401, 102\u2013113. [CrossRef] [PubMed]90. Lee, H.E.; Jeon, S.J.; Ryu, B.; Park, S.J.; Ko, S.Y.; Lee, Y.; Kim, E.; Lee, S.; Kim, H.; Jang, D.; et al. Swertisin, a C-glucosylflavone,ameliorates scopolamine-induced memory impairment in mice with its adenosine A1 receptor antagonistic property. Behav. BrainRes. 2016, 306, 137\u2013145. [CrossRef]91. Wu, C.; Shen, J.; He, P.; Chen, Y.; Li, L.; Zhang, L.; Li, Y.; Fu, Y.; Dai, R.; Meng, W.; et al. The \u03b1-glucosidase inhibiting isoflavonesisolated from Belamcanda chinensis leaf extract. Rec. Nat. Prod. 2012, 6, 110\u2013120.92. Choi, C.W.; Cha, M.-R.; Park, J.H.; Kim, Y.S.; Yon, G.H.; Hong, K.S.; Ryu, S.Y. Glucosidase Inhibitors from Seed Extract of Paeonialactiflora. J. Korean Soc. Appl. Biol. Chem. 2009, 52, 638\u2013642. [CrossRef]93. Wu, Y.; Li, S.; Liu, J.; Liu, X.; Ruan, W.; Lu, J.-W.; Liu, Y.; Lawson, T.; Shimoni, O.; Lovejoy, D.B.; et al. Stilbenes from Veratrummaackii Regel Protect against Ethanol-Induced DNA Damage in Mouse Cerebellum and Cerebral Cortex. ACS Chem. Neurosci.2018, 9, 1616\u20131624. [CrossRef]94. Falomir, E.; Lucas, R.; Pe\u00f1alver, P.; Mart\u00ed-Centelles, R.; Dupont, A.; Zafra-G\u00f3mez, A.; Carda, M.; Morales, J.C. Cytotoxic,Antiangiogenic and Antitelomerase Activity of Glucosyl- and Acyl- Resveratrol Prodrugs and Resveratrol Sulfate Metabolites.ChemBioChem 2016, 17, 1343\u20131348. [CrossRef]"}